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John R oiiin Hofstetter, Ph.D.
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An understanding of a microbial reduction of the anthracycline
a n tib io tic ,

steffimycin

(1 )

was approached

from two directions.

F ir s t, the NADH-dependent enzyme responsible fo r the reduction was
purified

from

the

Streptomyces

steffisburqensis

cytosol

and

characterized.

Second, information was obtained on the reduction

and oxidation of

1

The

.

enzyme was a single polypeptide chain, acid ic , and stable

insolution.

I t had a molecular weight of 80,000 and

no prosthetic

groups.
The 5-step p u rificatio n process resulted in greater than 1,000fold

p u rificatio n

extracts
The
whose

and a 9% yield

of the homogenous

enzyme from

of S. steffisburqensis c e lls .
enzyme reduced 1 by a two-electron mechanism to a compound
properties

resembled

thoseof

other

anthracycline

hydroquinones, i . e . , no vis ib le chromophore, auto-oxidation to
a ir , more polar than 1, absorbance

at 254 nm 10-fold

1

in

greater than

that of 1, and no ESR spectrum.
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Due to
reduction

oxidation

reactions

of

were

this

product

observable

in

aerobic

using

solutions

an oxygen

Unfortunately we observed product formation

the

electrode.

only by sampling an

anaerobic reaction mixture at intervals and analyzing these samples
by

reverse

phase

hplc.

Spectroscopically

monitoring

the

NADH

concentration in aerobic reaction mixtures was the assay used for
most studies reported.
At

conditions

anthracyclines
steffim ycin,

used for

were

not

w arfarin,

enzymically

substrates

for

reducing
this

1,

therapeutic

enzyme.

Reduced

Cibachron Blue dye, and p-(hydroxymercuri)

benzoic acid, inhibited the enzyme.
In

the

second

approach

oxidative behavior of
reducing agents,
chromophore,

1

we

investigated

and in enzymic systems.

steffimycin

the

reductive

and

by electrochemical means, with inorganic

was

Upon reduction of the

sig n ific a n tly

chromophore-reduced therapeutic anthracyclines.

more

stable

than

Whereas, reduction

under any conditions of the 5,12 quinone groups of eith er daunomycin
(Daunorubicin) or adriamycin (Doxorubicin) with one or two electrons
produced a rapid and quantitative elimination of daunosamine to form
th e ir

respective

7-deoxyanthracyc1 i nones ;

s im ilarly

reacted neither as rapidly nor as qua n titatively.
s ta b iliza tio n of the reduced intermediate of

1

reduced

1

This indicates

.

Since the reduced intermediate of 1 is sta b ilize d , i t is a poor
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bioalkylating

agent.

This

uniquj chemistry fo r an anthracycline

lends weight to the bioalkylation theories of anthracycline to x ic ity
proposed by Moore, Bachur and others and reviewed in this work.

bT a'YSh^

OCH3

OH 0

OH 0

H O -^^ir^O C H g
Steffim ycin (1)
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CHAPTER I
INTRODUCTION AND LITERATURE REVIEW
Purpose
These studies were directed toward understanding the mechanism
fo r

a microbial

reductive

cycline a n tib io tic .
characterize

an

conversion of

To do this
enzyme

it

from

steffim ycin,

an anthra

was necessary to isolate and
Streptomyces

steffisburqensis

responsible for this conversion.
What follows

is background information that should be useful

fo r establishing the context of

the

laboratory studies

that are

reported la te r.
Anthracyclines
Anthracyclines are among the oldest an tib io tics known.
were discovered in 1939, in Russia.

They

A ll are produced by species of

eith er Streptomyces or Micromonospora and are usually isolated from
a

fermentation

solvent.
derivatives
glycoside.
sugar.
contain

medium

Anthracyclines
of

a

by

extracting

are a ll

the

whole

broth

red- or orange-colored

with

a

and are

7,8,9,10-tetrahydro-5,12-naphthacenedione

The saccharide group can contain one or more than one
Most

an

tumor-active

amine

functional

anthracyclines
group.

have

saccharides

The sugars

attach

to

that
the
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2
chromophore at eith er the seventh or ninth position; attachment at
the seventh position is the most common.
The structures

and common names of some anthracyclines that

researchers have used in metabolism and bioconversion studies are
shown in Table 1 and Figure 1.
Most anthracyclines are active against not only fungi and Grampositive bacteria but against certain viruses and tumors as w ell.
Their anti tumor a c tiv ity is therapeutically interesting.
Anthracycline Therapeutics
Of

the

100 or more known anthracyclines,

the Federal

Drug

Administration (FDA) has approved only adriamycin and daunomycin for
use against cancers.
currently

using

The Union of Soviet So cialist Republics is

carminomycin

in

daunomycin for treating cancers.
three compounds d iffe r
to x ic itie s ,

and

little ,

addition

to

adriamycin

and

Although the structures of these

they have much d iffe re n t potencies,

antineoplastic

spectra.

As

Table

2

shows,

daunomycin is useful for only acute leukemias; whereas, adriamycin
has

the

broadest

spectrum

of

any

known

anticancer

drug.

Carminomycin, although sim ilar to adriamycin, has a higher potency.
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Some o f the Anthracyclines Used in
Bioconversion Studies

Compound
Aclacinomycin A

Position of
phenolic groups

Ring A substituents at
positions 7
&
10

Other

4,6
? l

I f
.

Cinerubin A

1 4.6

CO2CH3

Adriamycin
(Doxorubicin) .

6,11

H

13-0x6,
14-0H.&
-OCH3

4

HO
Carminomycin

4 6.11

.

H

13-Oxo

Daunomycin
(Daunorubicin)

6.11

H

13-Oxo,
4-OCH.

Pyrromyci n

1 4.6

.

CO2 CH3
HO

Parts of the format o f this table are a fte r Remers (1979).
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(HgCY^.

OH

O HO H b

H -C O -^ Q
^
D 1 c

1B

OH O

HO H O

A

GHg

6cH g

Nogalamycin

Steffimycin (S) Ri=0 ,R2 =H
Steffimycin B Ri=0 ,R2 =CH3
Steffimycin C Ri=H2 ,R2 =CH3

H_CO
^

O HO
H

H O

"Adri amyci n

Figure 1.

Molecular structures of some unique anthracyclines.
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Table 2
Indications of Anthracyclines Currently Used in Chemotherapy

Compound

Diseases

Adriamycin (Doxorubicin)

Lung, breast, bladder, and thyroid
cancers
Soft tissue, bone, te s tic u la r, and
ped iatric solid tumors
Hodgkin's disease and non-Hodgkin's
lymphomas

Daunomycin (Daunorubicin)

Acute leukemias
Table 3

Adriamycin Toxicity

Acute;

Nausea
Vomiting
Diarrhea
Severe ir r ita tio n at intravenous
administration site

Delayed:

Bone marrow depression
Hair loss
Oral and gastrointestinal ir r ita tio n
Irrev ersib le c ard io to xicity
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6
A ll

useful

antineoplastic

anthracyclines are cytotoxic.

The

immediate problems that occur a fte r intravenous administration are
in Table 3 along with some of the chronic problems which develop.
Two of these chronic problems are dose-lim iting factors.
bone marrow depression and card io to xicity.

They are

The damage anthracy

cl ines do to the heart is both cumulative and irre v e rs ib le .

About

30% of a ll drug recipients develop heart fa ilu r e a fte r 550 m i l l i 
grams of

adriamycin

administered.

In

per

a ll

square meter

recipients

there

of

body surface has been

seems to

be progressive

decrease in the co n tractile a b ilit y of the heart.
Anthracvcline c yto to xicity and mutagenicity.
The
lim itatio n

cumulative
to

card io to xicity

its use; therefore,

of

adriamycin

is

a

major

sig n ifican t e ffo rt was directed

toward understanding the molecular basis of this to x ic ity .

There

was some evidence from the study of anthracycline derivatives that
this
toxic

understanding might
to

tumor c e lls .

in tra c e llu la r

aid

in

designing

compounds selectively

Anthracycline-damaged tissues demonstrate

and biochemical

changes.

The plasma membranes are

disrupted, and the mitochondria are swollen with distorted crista e.
There are breaks in the DNA, and the DNA- and RMA-polymerases are
inhibited.
they

Most anthracyclines are mutagenic in the Ames te s t, and

in h ib it

dehydrogenase,

the

following

adenylate

enzymes:

cyclase,

and

NADP-1inked

iso citrate

sodium-potassium-dependent

adenosine triphosphatase (Na-K-dependent ATPase).
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7
Although the mechanisms responsible for the observed changes
are

not

known,

changes.

at

least

three

These are outlined

theories

recognize the importance of biological
cyto toxicity.
reduction.

attempt

in Table 4.

to

explain

the

Two of these theories

reduction

in anthracycline

Figure 2 shows the two major products of chromophore
When reduced with two electrons,

the hydroquinone is

formed; when reduced with one, the semiquinone is formed.

O'

OH

OR^OH

OH

O

OR,

OH

OH

OR, OH

OH

Semiquinone

Figure 2.

O

OR,

Hydroquinone

Anthracycline chromophore reduction products.

The mechanism described by the f i r s t

theory is analogous to

that postulated for compounds lik e actinomycin and acridine dyes.
Anthracyclines intercalate between the bases of double-stranded DNA
and in h ib it strand separation.

The daunomycin complex with a six-

base sequence of DNA as established by X-ray crystallography is
shown in Figure 3.

This type of noncovalent binding inhibits DNA

rep lica tio n .

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

I

il
iil;l 1I II

II

àïï

I

I
i il

ii%

î!

I

^

cO

J

î

I

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

S p ace-filling view

I=

Daunomycin carbon

O'

stick model

Figure 3.

Daunomycin DNA complex.

Quigley and Wang (1981).
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The mechanism proposed by the second theory involves the non
specific

alkylation

anthracyclines.

of

c e ll

Once reduced,

components

by

the

reduced

anthracyclines may e lectro n ic ally

rearrange to form eith er 7-deoxyanthracyc1 inone quinone methide or
7-deoxyanthracyc1i none

semiquinone.

These

are

targets

for

nucleophilic attack by both cytoplasmic and nuclear components.
mechanistic

sequences

for

bioalkylation

of

both

one-

The

and

two-

electron-reduced chromophores is outlined in Figure 4.
The last theory attributes
radicals

generated

Hydroquinones
oxygen.

when

transfer

the cytotoxicity to the hydroxyl

the

reduced

anthracyclines

eith er

one or

two electrons to molecular

a ir-o x id iz e .

A one-electron transfer generates both superoxide and the

semiquinone.

Semiquinones

autoxidize

starting compound and superoxide.
cycle may occur repeatedly,
many superoxide radicals.

rapidly

to

the

quinone

Since this reduction-autoxidation

each anthracycline molecule produces
Superoxide in aqueous solution

is

in

equilibrium with hydrogen peroxide (H2 O2 )» hydroxide ions (OH"), and
hydroxyl

radicals

highly reactive.

(OH").
It

is

The hydroxyl
known to

radical

in partic u lar

damage cells

in

several

is

ways

including peroxidizing lip id s , causing breaks in the DNA polymer,
and damaging membranes.
The

above

theories

are

a ll

consistent

with

anthracycline

biochemistry and each most lik e ly has varying importance depending
upon both the anthracycline and the tissues being affected.
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>C-CHpH

>C-CHpH
OH

Adriamycin
Hp-0 HO HO (-1 o

Hp-O HO HO |_| o
o"

Daunosamine

Semiquinone

Hydroquinone
HO

c-cnpH

OH

lonucleophil
(No:)

r

°

qui none
methide

r

- ,> C - C H p H

9

"

np-Ô
c -cnpH

O HO H H
7-deoxyadriamycinone

Alkylated Biomolecule

Figure 4.

Two postulated mechanisms for bioreductive alkylation
by adriamycin. Oki, Komiyama, Tone, In u i, Takeuchi, and
Umezawa (1977), Bachur (1979), & Moore (1977).
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Most anthracyclines are also potent chelating agents.

Since

adriamycin binds calcium, and Na-K-dependent ATPase requires calcium
for

its

a c tiv ity ,

in hibitio n

of

chelation

this

is thought to be responsible fo r the

enzyme.

Adriamycin

has also

been shown to

in h ib it c e llu la r ion transport.

Adriamycin's marked cardiotoxicity

has been

to

a ttrib u te d ,

in

part,

this

chelating

a b ilit y .

The

discovery that the t r i f e r r i c complex of adriamycin, quelamycin, has
,a

therapeutic

ra tio

better

than

adriamycin's

supports

this

(Gosalvez, Blanco, Vivero, and Valles, 1978).
Anthracycline conversions at Upjohn
The Upjohn Company in Kalamazoo, Michigan has been successful
in

producing

plant

prompted

interesting

using microbial

the

biological
Upjohn

therapeu tically

steroids

National

Cancer

In s titu te

hormones from

conversions.

(NCI)

to

This

contract

a

and chemical anthracycline conversion program with The

Company.

derivatives

It

with

card io to xicity.

focused on the
good

. antitumor

production
a c tiv ity

of

anthracycline
and

reduced

One. of the important compounds to come from the

chemical derivatizatio n

effo rts was a modified nogalamycin called

7(^)-0-methylnogaro1 (7-OMEN, U-52047).
Figure 5.

steroidal

and chemical

The structure is shown in

I f the results from p reclin ica l testing continue to be

favorable i t w ill probably become a useful new antitumor drug.
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7 { ^ - 0 -methyl nogarol
(7-OMEN)

Figure 5.

Structure of 7-OMEN:
derivative.

A semisynthetic nogalamycin

There is evidence that 7-OMEN interacts only weakly with DNA.
Despite this and its re la tiv e lack of DNA-polymerase in h ib itio n at
lethal doses, i t
cell

cycle.

is nevertheless potently cytotoxic throughout the

This

suggests

that

7-OMEN's

mechanism of

action

involves chemistry other than that of DNA binding (Bhuyan, N e il, L i,
McGovren, and Wiley, 1980).
Unfortunately,

none

of

anthracycline derivatives.

the

bioconversions

produced

useful

Either the metabolites were in active, as

toxic as the original compounds, or so insoluble that they could not
be e ffe c tiv e ly administered.
Biological Oxidation and Reduction
Biological

oxidation

and

reduction

w ill

be

abbreviated

to
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bioredox

throughout

the, remainder

of

this

dissertation.

As

indicated, the enzymic reduction and oxidation of anthracyclines is
important to

both th e ir

to x ic ity

and th e ir

a c tiv ity .

For th is

reason what follows is a b rie f outline of the current concepts in
bioredox chemistry.
When the products of a reaction d iffe r from the reactants in
ways that cannot be accounted for by protons, hydroxide ions, halide
ions, or th e ir equivalents (water, hydrogen halide, ammonia, e t c . ) ,
then a redox reaction has occurred.

In the course of a bioredox

reaction, electrons are transferred from a reduced substrate to an
oxidized

cosubstrate

or

coenzyme.

In

most

aerobic

biological

systems molecular oxygen is the common, terminal electron acceptor.
Bioredox
systems.
reduced
forms.

is

Cells
organic

central
use

to

energy

flow

the energy released

m aterials

and

trap

it

and

supply

in

liv in g

from the oxidation
in

b io lo g ic ally

of

useful

These include nucleotide triphosphates, reduced nucleotides,

or membrane potentials.
Enzymes catalyzing bioredox reactions usually require cofactors
and contain one or more prosthetic groups.
alone

contains

electrons.

fu n ctio n alities

capable of

No polypeptide chain
storing or

conducting

The prosthetic groups usually associated with bioredox

enzymes

serve

between

the

as channels

1978).

The common coenzymes are nicotinamide adenine dinucleotide

substrate

and

for
the

low-energy electronic
cosubstrate

or

interchange

coenzyme

(Walsh,
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(NAD),

nicotinamide adenine dinucleotide phosphate (NADP), fla v in

adenine dinucleotide
include heme,

(FAD),

and pterin s.

ions such as copper, iro n, or molybdenum.
enzymes are associated with
within the c e l l.
role

The prosthetic groups

iro n -s u lfu r, fla v in mononucleotide (FMN), and metal
In addition, most redox

and bound to the membrane fractions

This location is , of course, essential to th eir

in general

electron

transport and the establishment of the

membrane potentials mentioned before; however, much about bioredox
chemistry remains unknown.

Furthermore, redox enzymes are generally

more complex and th e ir mechanisms less well

understood than the

mechanisms of most other enzyme classes.
At least two aspects of anthracycline bioconversion studies are
universally important.
second

involves

The f ir s t of these involves bioredox; the

the therapeutic potential

of the anthracyclines.

Apparently the reduction and oxidation cycle of the anthracycline
quinone moiety seems important to both the a c tiv ity and to x ic ity of
the drugs.

Increasing the understanding of this cycle in enzymic

systems can provide new insight
enzymes.

into

the mechanisms of bioredox

Also, improved understanding of th e ir biochemistry may aid

in compounding and combining drugs, designing or discovering new
anthracyclines,

and/or

establishing

a regimen for

administration

that helps m itigate th e ir to x ic ity to normal c e lls .
Although

the

purpose

partic u lar microbial

of

this

work

was

to

characterize

conversion of one anthracycline, i t

a

is hoped
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that the information obtained from these studies might also provide
general

information

about

anthracycline

bioconversions,

bioredox

enzymes, and microbial metabolism.
Steffimycin
Steffimycin and nogalamycin are two anthracyclines discovered
and characterized at

The

UpjohnCompany.

bioconversion studies

and

therefore should beincluded in Table 1,

but

the

arrangement

therefore, do not f i t
structures.

of th e ir

substituents is

the

They were both used in

unique.

They,

formatof the table. Figure

Adriamycin is

1

shows th e ir

included in the figu re for comparison

with the anthracyclines in Table 1.
Since

there

was

a

large,

readily

available

supply

of

steffimycin at The Upjohn Company and i t was less toxic than other
anthracyc lin es ,

i t was the substrate used most frequently in this

investigator's studies.
Bergy
steffimycin
They

also

and

Reusser

from the

(1967)

of

fermentation

established

the

The

Upjohn

Company

broth

of ^

steffisburqensis.

molecular

u ltra v io le t-v is ib le spectrum, to x ic ity ,
the drug.

formula,

isolated

molecular

weight,

and a n tib io tic spectrum of

Table 5 summarizes the properties determined.

Although

steffimycin had no in vivo antibacterial a c tiv ity and l i t t l e in vivo
antineoplastic a c tiv ity ,

Bergy and Reusser determined that its

in

v itro a c tiv ity resulted from the inhibitio n of RNA synthesis.
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Table 5
Properties of Steffimycin
Molecular weight

WR

Absorbance maxima

inmethylene chloride

440nm, 280 nm, 236 i

Log of the molar extinction coefficients

4 .2 ,

LDgQ (ra ts )

562 mg/kg

In v itro antibacterial spectrum

Staphylococcus aureus
Streptococcus faecal is
hemolyticus

The

K elly,

S chletter,

Upjohn

Company

4 .3 , and 4.5

Koert, MacKellar, and Wiley (1977) also

of

determined

of

the

molecular

structure

steffim ycin.
Assays
The

anthracycline

bioconversions

reported

next

can

be

represented by the following reaction:

anthracycline + «^educed
enzyme
oxidized
\rma preparation""
nv^ûnav^ar i r\n^ coenzyme
r-r\r\rt *7i /tyiq
coenzyme
To

follow

these

enzymic

anthracycline reductions

researchers monitored the changes versus
of

coenzymes,

studied

oxygen, and/or

included

the

reduced
anthracycline

time in

reducedproducts.

following:

(i)

0.2JM to

previous

the concentration
The
O.Oljl

variables
of

eith er

potassium phosphate or t r i s( hydroxymethy1 ) ami nomethane hydrochloride
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(Tris-HC l) at pH's from 7.4 to 9.0 (0 .1 ^ phosphate buffer at pH 7.5
was the most common); ( i i )

0

. 01^1 to the maximum s o lu b ility at room

temperature (RT) of the anthracycline; and ( i i i )
the appropriate coenzyme.
then

the

coenzyme

concentration

spectrophotometrically

at

concentration

were measured

changes

manometrically.

O.lmM to 20mM of

I f the coenzymes used were NADH or NADPH
changes

a wavelength

of

eith er

measured
The oxygen

polarographically

or

The concentration changes of reduced anthracycline

products were measured in one or both of two ways.
method of

were

340 nm.

The most common

analysis was to extract the reaction mixture with

an

organic solvent, spot an aliquot of the extract onto a s ilic a thin
layer

chromatography

appropriate
formed

solvent

by

determine

(tic )
system,

fluorescence
the

presence

plate,

develop the

densitometry.
of

plate

and measure the amounts

the

The

reduction

second

products

with

an

of products
way was
in

to

solution

d ire c tly , e .g ., the presence of the semiquinone using electron spin
resonance (ESR).

Both the Lowry assay and the absorbance at 280 nm

were used to determine the protein concentrations in solutions.
fa r

as

one

following

can

studies

determine,
were

a ll

variations

the
of

enzyme assays used in
the

basic

assay

As
the

methods

described.
Anthracycline Nomenclature
The nomenclature and the ring labelling of the anthracyclines
has not been standardized; therefore, the names given to the same

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

19
anthracycline derivatives in the lite ra tu re are often as numerous as
the number of researchers publishing in this f ie l d .

What follows is

the nomenclature that seems to be the most widely accepted and that
which the investigator used throughout this d issertation.
The

chromophore

aglycone.

alone

is

called

an

anthracyclinone

or

I f i t is reduced at the seventh carbon i t is called the

7-deoxyaglycone or 7-deoxyanthracyc1inone.
are aclacinomycin and nogalamycin.

Two exceptions to this

In the case of aclacinomycin the

aglycone is called ak lav inone, and in the case of nogalamycin the
aglycone is called nogalarol.

An anthracyclinone reduced at a side

chain keto-group (usually found at eith er the 10th or 13th carbon)
is called

an anthracyclino1.

Anthracycline glycosides reduced at

eith er the 10th or 13th carbon are called 10- or 13-dihydroanthracyclines.

Figure

6

shows

the

basic

structures

and

the

two

exceptions.
Anthracycline Bioconversions
What follows is a selected, chronological lite ra tu re summary of
both

mammalian and m icrobially

catalyzed

conversions

of

various

anthracyclines.
In 1971, Bachur of NCI in Baltimore, Maryland, id en tified the
major metabolic product of daunomycin found in human urine.

I t was

13-d i hydrodaunomyc in.
In

1972,

Bullock,

Bruni,

and Asbell

at

Arthur

D.

L ittle
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Œ

%JT

OR O

OH

fO H

Anthracycline; X - saccharide
Anthracyclinone; X = OH

X

9
13-di hydroanthracycl i ne ; X = saccharide
Anthracyclinol; X = OH

OH

^
JoH ^

OR O

O

»

OH

X

O

7-deoxyanthracyclinone
OR O

OH

Aklavinone

D î TQ
OH O

I

OH

o
OH O

Figure

OH OH

6

.

Nogalarol

OH OH

Anthracycline nomenclature.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

21
Incorporated

in

Cambridge,

Massachusetts

id e n tifie d

two

more

bioconversion products that resulted from anaerobically incubating
eith er daunomycin or adriamycin with crude ra t liv e r homogenate and
NADPH.
magnetic

The metabolites
resonance

id en tified

(FT-PMR)

and

by Fourier
mass

transform proton

spectra

(ms)

were

7-

deoxydaunomycinol, 7-deoxyadr i amyc i no1, 7-deoxydaunomycinone, and 7deoxyadr i amyc inone.

They

established

that

the

c e ll

extracts

produced these compounds by an unusual reductive cleavage of the 70-glycosidic

linkage of the anthracyclines.

Figure 7 shows the

structure of the metabolites that they id e n tifie d .

9

.

HO

R=OH 7-deoxyadriamycinol
R=H 7-deoxydaunomycinol

Figure 7.

or 7-deoxyadriamycinone
or 7-deoxydaunomycinone

Common anthracycline metabolites in humans.
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Felsted, Gee, and Bachur (1974)

isolated an enzyme from ra t

liv e r responsible for the conversion of adriamycin and daunomycin to
th e ir 13-di hydro-derivatives.
Handa

and

Tuberculosis,

Sato

Leprosy

(1975*)
and

at

Cancer

the
in

Research
Tohoku

In s titu te

University,

for

Japan,

reported that quinone-containing anticancer drugs in itia te d s u lfite
oxidation when incubated with NADPH and ra t liv e r microsomes.
oxidation of s u lfite

The

by oxygen is believed to be a free radical

reaction in itia te d by eith er the univalent oxidation of s u lfite or
the

univalent

phenomenon

reduction

was

intermediate

of

evidence

formed

oxygen.

that

during

a

this

They

free

suggested

radical

bioreduction

that

or

this

semiquinone

reaction.

They

attributed these observations to the following reaction sequences:

Adriamycin^system^'X^^^^*^*"iamycin Semiquinone
NADPH + H
Then
microbial

Wiley

NADP

O2

Adriamycin ^ O2 +

and Marshall

(1975)

at

Upjohn

2 SG3 - * 2 SÜ4

reported

on the

reductive conversion of the anthracyclines steffim ycin,

steffimycin B, nogalamycin,

steffimycinone,

and daunomycin.

They

obsèrved that the 7-deoxyaglycones of these anthracyclines formed
when

they

were

incubated

with

unagitated,

dialyzed,

c e ll-fre e

extracts (c fe 's ) of Aeromonas h.ydrophilia and NADH.
By 1976, Bachur and Gee reported that the glycosidic cleavage
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and the reduction at the seventh carbon seemed simultaneous; that
the reduction was associated with the microsomal c e ll fraction and
required NADPH; and that the reaction occurred only in oxygen-free,
microsomal preparations.
Marshall, Reisender,
reduction

products

and Wiley (1976)

generated

in

studied the daunomycin

dialyzed

cfe's

of

S.

steffisburqensis to which varying concentrations of eith er NADPH or
NADH had been added.
these

mixtures

chromatography

They analyzed methylene chloride extracts of

by

eith er

(hplc).

s ilic a

^

t ic

or

high

steffisburqensis

pressure

cfe's

liqu id

produced

7-

deoxydaunomycinone and 7-deoxydaunomycino1 from more than 60% of the
daunomycin starting m aterial.
not

only

seemed

d erivative,

to precede

but

i t required

The production of the 7-deoxyaglycone
the

formation

NADH.

of

The

the

13-dihydro

formation

of

7-

deoxydaunomycinol was NADPH-dependent.
Also in 1976, Marshall, Reisender, Reineke, Johnson, and Wiley
reported

reductions,

sim ilar

to

those

Bachur

observed,

of

daunomycin, nogalamycin, steffim ycin, steffim ycin B, steffimycinone,
and

cinerubin

A

by

anaerobic,

dialyzed,

cfe's

of

Aeromonas

hydrophila. Citrobacter fre u n d ii. and Escherichia coli to which NADH
had been added.
In 1977, M. E. McCarville, while on sabbatical
Michigan
Company.

University,
During

worked

with

V.P.

Marshall

at

from Western
The

Upjohn

this collaboration, they isolated a crude enzyme
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(50% pure) responsible for the simultaneous reduction and glycosidic
cleavage

of

steffimycin

from

the

cfe

of

Aeromonas

hydrophila.

However, the enzyme appeared to have properties d iffe re n t from most
standard redox enzymes—the u ltr a v io le t-v is ib le (uv-vis) spectrum of
the enzyme preparation was not indicative of a fla v in , iro n -s u lfu r,
or other prosthetic group; nor was the a c tiv ity membrane-bound.
The next microbial conversions studied by Wiley, Koert, Elrod,
Reisender, and Marshall

(1977) at The Upjohn Company (part of the

program designed to generate new antitumor agents) used steffimycin
as the substrate.
c e ll-fr e e

The enzyme mixtures they used were derived from

preparations of Streptomyces noqalater and Streptomyces

peucetius.

They found an NADPH-1inked reduction of steffimycin to

10-dihydrosteffimycin

and

reductive

elim ination

to

7-

deoxysteffimycinone.
In

1977,

Oki,

Komiyama,

Tone,

In u i,

Takeuchi

and

Umezawa

published studies on the mammalian metabolism of aclacinomycin A.
They

digested

the

metabolizing

enzyme

away from

the

r a t -liv e r

microsomal particles with trypsin and p u rified i t by gel f ilt r a t io n
and

diethyl

aminoethyl

(DEAE)-cellulose

chromatography.

Under

anaerobic conditions the purified enzyme both reductively c.eaved
the

aclacinomycin

chromophores.

À to

its

7-deoxyaglycone,

and

dimerized

the

The dimer consisted of two 7-deoxyaklavinones joined

at th e ir seventh carbons.

The presence of the apparent dimerization

product of a carbon-centered free radical was strong evidence fo r a
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free radical

intermediate

in this

reduction

(Mason,

1979).

The

isolated enzyme also reduced the following anthracyclines to th eir
respective 7-deoxyaglycones:

adriamycin, adriamycinone, daunomycin,

daunomycinone, and 13-di hydrodaunomyc inone.
had

a uv-vis

exhibited

spectrum

sim ilar

NADPH-oxidase

to

a c tiv ity

following:

vitamin

dichlorophenol

indophenol

K3 ;

that
also

The enzyme preparation
of

in

enzyme-reduced

(DCIP);

a flavoenzyme.
the

presence

cytochrome

of
c.;

and potassium ferricyanide,

Mercuribenzoate inhibited the enzyme.

It
the
2 ,6

-

p-

These results indicated that

the enzyme was sim ilar to an NADPH-cytochrome c. reductase.
Sato, Iwaizumi, Handa, and Tamura (1977) confirmed, using ESR,
that a stable free radical intermediate formed as NADPH (plus one of
the

following:

adriamycin,

with r a t -liv e r microsomes.

daunomycin,

or carboquone)

incubated

They associated the ESR signal observed

with the anthracycline semiquinone.
Goodman and Hochstein

(1977)

of

the

University of Southern

C alifornia School of Medicine in Los Angeles, C alifornia observed
that in mixtures of pu rified cytochrome P-450 reductase, NADPH, and
eith er adriamycin or daunomycin the to ta l
excess

of

observation

the

to ta l

was

drug

caused

by

present.
the

oxygen depleted was in

They postulated

repeated

reduction,

that

followed

this
by

autoxidation of the anthracycline quinone groups.
Bachur,
anthracyclines

Gordon

and

they

tested

Gee

(1977)

reported

that

a ll

the

increased the oxygen consumption when
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incubated with NADPH and r a t -liv e r microsomes.

They also used ESR

to monitor the reduction and assigned the signal observed to the
semiquinone free rad ical.

They reported that chemical reduction

bleached aqueous anthracycline solutions.
By 1978, Bachur, Gordon, and Gee postulated a general mechanism
by which microsomes activated quinone-containing anticancer drugs to
free radicals.

They sought to explain the following:

a n tibio tics

seem to. cause

activation;

quinone

chromosomal

groups

may

damage

in te rfe re

anthracycline

only

with

a fte r

bio

mitochondrial

oxidative pathways; both streptonigrin and mitomycin C (two other
quinone-containing anticancer compounds) are active only a fte r they
are reduced;

the enzymic NADPH consumption rate

oxygen consumption rate both increase
cycl ines;
the

and fin a lly ,

exception

signal.

Figure

of
8

and the enzymic

in the presence of anthra

bioactivated quinone-containing drugs—with

mitomycin

C—produced

a

characteristic

shows the mechanism they proposed.

ESR

Adriamycin,

daunomycin, carminomycin, rubidazone, nogalamycin, aclacinomycin A,
steffim ycin,

mitomycin

C,

streptonigrin,

and

lapachol

are

converted to free radical forms by microsomal flavoproteins.

a ll
The

radical forms then selectively bind to and covalently modify DNA.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

DNA
RNA
e tc .

Flavoprotein
NADPH

(Red)
Flavoprotein

NADP

Figure

8

.

Proposed mechanism: Microsomal activation of quinone
anticancer agents (Bachur, Gordon, and Gee, 1978).

Marshall, McGovren, Richard, Richard, and Wiley (1978) reported
on the microbial metabolism of daunomycin and adriamycin by both the
fungus,

Mucor

spinosus.

and the

bacterium

steffisburqensis.

These organisms metabolized the anthracyclines in a manner sim ilar
to the way mammalian cells metabolized them.

The fungus and its

cfe's reduced the 13-keto group of daunomycin to the hydroxyl at the
expense of NADPH; the S. steffisburqensis c fe 's , on the other hand,
both

reductively

deoxyaglycones at

cleaved

adriamycin

and daunomycin to

th e ir

7-

the expense of NADH and also converted the 7-

deoxyaglycones to 7-deoxydaunomycino1 or 7-deoxyadriamycinol at the
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expense of NADPH.
In

1978,

M e rritt

(Note

4)

of

the

Physical

and Analytical

Chemistry Division of The Upjohn Company used ESR to investigate the
free radicals formed when the anthracyclines daunomycin, adriamycin,
7(^)-0-methylnogaro 1,

and 7(S^).-0-methylnogarol were incubated with

NADPH and ra t liv e r microsomes.

A ll the drugs examined produced a

detectable free radical signal under these conditions.

The signal

shape was sim ilar to those published for other qui noid anticancer
drugs (Bachur et a l.
concentrations

of

1977; and Sato et a l.
microsomally

saturated

anthracycline

asserted

that

the

1977).

generated

solutions were only

g-values

of

the

However, the

radical

species

lQ -% .

signals

in

M e rritt also

observed

might

be

inconsistent with those produced by stru c tu ra lly sim ilar, chemically
generated,

semiquinone

electrochemical

data

radicals.

to

thermodynamically more

show

stable

that
than

Furthermore,

she

used

superoxide

radical

was

the
the

anthracycline

semiquinone

radicals.
Meanwhile Bachur, Gordon, Gee, and Kon (1979) continued th eir
investigations

into

the

enzymic

reduction

of

anthracyclines

expanding on the work of Goodman and Hochstein.
cytochrome
mitomycin

P-450
C,

reductase

adriamycin,

aclacinomycin A.

was

used

daunomycin,

to

by

Purified NADPH

reduce

carminomycin,

streptonigrin,
7-OMEN,

and

A ll except mitomycin C produced ESR signals that

could be attributed

to

a semiquinone free

radical intermediate.
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Bachur et a l.

reiterated the postulate that the cytotoxic form of

these drugs was the semiquinone free ra d ic a l.
The

same

year

Bachur

published

anthracycline

metabolism.

In

mechanism for

the

cleavage

reductive

th is

a

general

he

outlined

of

daunomycin

review
a

of

postulated
and sim ilar

anthracyclines by NADPH cytochrome P-450 reductase and enzymes lik e
it.

The mechanism is shown in Figure 9.

NADP'
H3 C 0

02

0

OH

OH

OH

0 Sugar

NADPH + H"
OH

7-Deoxyaglycone

Figure 9.

A mechanism fo r reductive aglycone formation (Bachur,
1979).
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The reduction of the anthracycline, in itia te d by a one-electron
transfer from a reduced flavoenzyme, forms the semiquinone.

The

semiquinone reduces molecular oxygen to superoxide (Og*)* whereupon
it

becomes the origin al anthracycline quinone.

In the absence of

oxygen the semiquinone e lectro n ic ally rearranges, the bond between
the

seventh carbon

and oxygen s p lits ,

and the products—the

deoxyanthracyc1inone plus the sugar—form.

7-

Bachur also called the

anthracycline semiquinones "site -s p e c ific free radicals"; although,
the nature of the resulting complex was not c la r ifie d nor was th e ir
s p e c ific ity defined.
To compare the nogalamycin metabolites produced in mammalian
systems with those produced in microbial systems, Rueckert, Wiley,
McGovren, and Marshall (1979) incubated nogalamycin with both r a tliv e r homogenates and Streptomyces noqalater c fe 's .
converted nogalamycin to 7-deoxynogalarol.
requirements

for

Both systems

However, the coenzyme

the conversion were d iffe re n t

for each system.

NADPH was required for the reductive cleavage in mammalian cells ;
microbes required NADH.
Komiyama, Oki, In u i, Takeuchi, and Umezawa (1979) reported on
th e ir comparison of the reductive cleavage of aclacinomycin A to 7deoxyaklavinone
mitochondrial,

by various
lysosomal,

r a t - 1 iver

c e ll

microsomal,

and

fractions:
soluble.

nuclear,
They

also

compared the reductive conversion rate in the presence of NADPH with
that

in

the presence of NADH fo r each of these fractions.

The
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microsomal fraction had the highest turnover of a ll c e ll fractions
tested, and a ll c e ll fractions produced the 7-deoxyaglycone faster
in the presence of NADPH than they did in the presence of NADH.
In

the

same year,

Komiyama,

Oki,

and

Inui

reported

studies on aclacinomycin A, adriamycin, and daunomycin.
purified

enzymes—xanthine

dehydrogenase,

and

anthracyclines.
oxidase

dimer.

It

the

and

also

conversion

of

mitochondrial
reductively

When xanthine was the

catalyzed

deoxyaklavinone

oxidase,

DT-diaphorase—to

the

NADH-

cleave

the

electron donor,

xanthine

aclacinomycin A to

both 7-

7 , 7 '-b i s(7 -deoxyak1 av i none) ,
catalyzed

th e ir

They used

conversion

of

the

chromophore

adriamycin

and

daunomycin to th e ir respective 7-deoxyaglycones using xanthine as
the electron donor.
dimerized.
catalyzed

However, neither adriamycin nor daunomycin were

Both mitochondrial NADH-dehydrogenase and DT-diaphorase
sim ilar

conversions

in

the presence of NADH but at a

slower rate than that of xanthine oxidase under sim ilar conditions.
Pan
xanthine
determined

and

Bachur

(1980)

oxidase-catalyzed
the

rate

of

expanded

the

anthracycline

daunomycin-affected

investigation
conversions.
oxygen

of

the
They

consumption,

examined the radicals formed during the reduction process using ESR,
and compared the deflavoenzyme to the holoenzyme with respect to the
effe ct various electron donors had on reduction.

Xanthine oxidase

used the electron donors xanthine, glycoaldehyde, purine, NADH, and
NADPH as coenzymes to convert daunomycin to 7-deoxydaunomycinone.
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The most effe ctive electron donor for the xanthine oxidahe-catalyzed
cleavage of daunomycin was NADH; pterin was not e ffe ctive as an
electron donor.

A ll samples yielding the 7-deoxyaglycone product

produced an ESR signal.

The deflavoenzyme was inactive.

When xanthine, glycoaldehyde, and purine were electron donors
fo r the reduction, the oxygen consumption was in h ib ited , but these
data seem to cast doubt on the mechanism that Bachur (1979) proposed
(outlined

in

mechanistic

Figure

9 ).

sequence

The

diagrammed

electron
is:

flow

from

implied

electron

flavoprotein, to anthracycline and then to oxygen.

in

the

donor

to

That sequence

should be unaffected by the type of electron donor used.
Kalyanaraman, Perez-Reyes, and Mason (1980) at the Laboratory
of

Environmental

Biophysics

of

the

National

In s titu te

of

Environmental Health Sciences in North Carolina used both standard
ESR

and

spin-trapping

semiquinones

generated

starting materials were:

ESR
by

techniques
microsomes.

to

study

The

adriamycin, daunomycin, and mitomycin C.

The structure of mitomycin C is shown in Figure 10.
in addition,

none

species were generated in

were

They designed,

a flow-through ESR cell to observe the signals from

s h o rt-lived , mitomycin C semiquinones.
radical

anthracycline

quinone-containing

present

in

A ll observable anthracycline

anaerobic, microsomal

oxygenated

solutions.

The

Kalyanaraman used was 5 ,5 '-d im e th y l-l-p y rro lin e -l-o x id e .
nitroxide

adducts

with

superoxide

(Og^).

The

systems;

spin

trap

It

forms

adduct

was
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s u ffic ie n tly

stable for

temperature.

its

On the other

ESR signal
hand,

to

be detectable at room

the anthracycline

semiquinones

produced ESR signals detectable for hours in anaerobic solutions at
room temperature.

The authors

disproportionation

reaction

attributed this

and

not

to

to the following

the s ta b ility

of

the

semiquinone:
2A^ +

2H+

A+

AHg

In this case. A* represents the semiquinone, A the anthracycline,
and

AHg

radical

the
is

e q u ilib ria
radicals

hydroquinone.

The

being continually
may p a r tia lly

observable

in

anthracycline

destroyed

explain

both

anaerobic

the

solutions

semiquinone

and reformed.

free
These

low concentration
and

the

of

pH optimum

observed for the enzymic reductive cleavage.

Figure 10.

Structure of mitomycin C.
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In

addition

Kalyanaraman f e lt

that

the

last

two mechanisms

outlined in Table 4 for the cytotoxicity of the anthracyclines could
not be operating simultaneously.

One theory centers on the to x ic ity

of the anthracycline semiquinone and another on superoxide to x ic ity ,
but the presence of one species in the in tra c e llu la r f lu id seems to
preclude the presence of the other.

According to these authors the

rate of the reaction of semiquinone with oxygen going to superoxide
and qui none is about two orders of magnitude fa s te r than the reverse
reaction.

ibo riwe: "2' ' r
The

semiquinone

would

be

autoxidized

rap id ly

whenever

the

in tra c e llu la r oxygen concentration was s u ffic ie n t for mitochondrial
function;

therefore, the life -tim e of the semiquinone under these

conditions would be shorter than the time needed fo r the reactive
species to diffuse
out,

into the nucleus.

This s itu a tio n , they point

would not necessarily hold for

tumors poorly perfused with

oxygen.
Recently,

Pan,

Pedersen,

and

Bachur

(1981)

compared

the

following enzymes on the basis not only of the reductive cleavage of
daunomycin but also of the daunomycin-affected oxygen consumption:
NADPH

cytochrome

reductase,

P-450

reductase,

xanthine

NADH cytochrome c_ reductase,

oxidase,

lipoamine

n itra te

dehydrogenase,

glutathione reductase, L-amino acid oxidase, D-amino acid oxidase,
D-glucose oxidase, and la c tic acid dehydrogenase.

The f i r s t four of
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these flavoenzymes are supposed to work by a one-electron-at-a-tim e
reduction

mechanism.

The

remaining

concerted two-electron tra n sfer.

flavoenzymes

work

enzymes catalyzed the reductive cleavage of daunomycin.
electron" type did not.
exception.

via

a

They found th at the "one electron"

However,

The "two-

lipoamine dehydrogenase was an

I t catalyzed the reductive cleavage of daunomycin to 7-

deoxydaunomycinone, but at a rate only 1/lOOOth that catalyzed by P450 reductase.
rate

in a ll

The oxygen consumption increased with the cleavage

but two cases:

the xanthine oxidase reaction using

xanthine as the electron donor and the lipoamide oxidase reaction
with NADH as the cofactor.

In both of these instances the oxygen

consumption decreased when daunomycin was added to the solution.
Most of the results obtained by the investigators cited above
are presented in tabular form in Appendices A through C.
Selected Anthracycline Chemistry
What

follow

are

some of

the

lite ra tu re

available

on

the

reactions of inorganic reducing agents with anthracyclines; on the
electrochemical
integral
chemistry.
and

to

reduction

th e ir

redox

of

anthracyclines;

chemistry,

on

and,

th e ir

since

aqueous

it

is

acid-base

This information may serve to indicate the k in e tic a lly

thermodynamically

favorable

conditions

for

reduction reactions at physiological conditions.

anthracycline
The information

may also bracket the possible products and intermediates generated
when

the

anthracycline

chromophore

discussed below are outlined in Table

is
6

reduced.

The

reactions

.
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Reducing Agents and Anthracyclines

Bafs^/P aTla d iu m ^

7-deoxydaunomycinone + daunosamine

(Arcamone, 1972)

2.

Daunomycin

■

^

7-deoxydaunomycinone + daunosamine

(Sm ith, 1976)

3.

Nogalamycin & /or 7-OMEN-------

—^

Free ra d ic a ls (semiquinone) by esr

( M e r r it t , Note 4)

4.

Steffim ycin

Palladium

5.

Anthracycline

Reducing
Agents

6.

Daunomycin

NaBHa

7.

Adriamycin

Aqueous
Base

(Bachur, 1977)

o H daunosamlne

MP*

8.

Anthracycline

9.

Anthracycline

N'aBHa

NaRHa

(p ostulated )

(Lown, 1977)

(p ostulated )

(P ie tro n ig ro , 1979)

H daunosamine

Bleached chromophore

(Pan , 1981)

(Arcamone, Note 1)
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Arcamone,
Selva

C a ssin elli,

(1972)

at

Franceschi,

Farm italia

Research

Penco,
of

Pol,

Milan

R edaelli,
reported

and
that

adriamycin was q u a n titatively converted to 7-deoxyadriamycinone plus
the aminosugar, daunosamine, when i t was reduced with hydrogen gas
over a barium sulfate-poisoned, palladium catalyst.
Smith,

Fujiwara,

Henry,

and Lee

(1976)

of

the

Bioorganic

Chemistry Department of the Stanford Research In s titu te , Menlo Park,
C alifo rn ia, while working on the chemical synthesis of adriamycin,
discovered that dith io n ite (SgO^^-) reductively cleaved daunomycin
in aqueous buffers to 7-deoxydaunomycinone and daunosamine.

The

reaction was quantitative a fte r 15 minutes at room temperature.
Kelly et a l.

(1977), who established the molecular structures

of the anthracyclines steffimycin and steffimycin B, produced the
respective 7-deoxyaglycones and steffose (or methyl steffose in the
case of steffimycin B) by hydrogenating these anthracyclines over
poisoned palladium.
In

the

same year

Lown,

Sim,

Majumdar,

and

Chang of

the

Department of Chemistry of the University of Alberta in Edmonton
reported

that

daunomycin,

a fte r

having

been

reduced

with

borohydride, produced strand scissions in covalently closed circu la r
DNA.

They postulated that the structure of the reduction product

that caused the damage to DNA was the hydroquinone derivative shown
in lin e six of Table

6

.

This derivative was colorless (Lown, Note

3 ).
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In

addition

anthracycline
solutions,

to

free

using

microsomal

radical

M e rritt

(Note

preparations

intermediates

4)

used

in

potassium

to

anaerobic
dioxide

to

generate
aqueous
convert

nogalamycin, 7-OMEN, and a few anthraquinone derivatives dissolved
in dimethyl sulfoxide

(DMSG) to th e ir corresponding semiquinones.

The chemically generated radicals had ESR signals sim ilar to those
formed by the microsomal system.
Rao,

Lown,

and

cyclic voltanmetry,
to

investigate

daunomycinone,
der iv a tiv e s :

the

Plambeck

1978b)

used

polarography,

aqueous chemistry of

daunomycin,

adriamycinone.

following

anthracycline

4-demethoxy-7-0-methy1daunomyc i none,

4-demothoxy-

and

6,7,11-trimethoxydaunomycinone,
daunomyci none,

(1973a,

and chronopotentiometry on a mercury electrode

and

The

adriamycin,

4-demothoxy-l, 6 , 7 , 11-tetramethoxy-

1 , 6 , 1 1 -tr im ethoxy-9-acetyl-5,12-naphthacene-

quinone were studied using cyclic voltammetry.
buffers (0 .1 ^ phosphate, pH

6

A ll were in aqueous

- 8 , and O.IM KCl).

Figure 11 shows

both the electrochemical and chemical processes they id en tified for
adriamycin and daunomycin.
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Hydroquinone

10 OH

1

o
-Cl ipH

HO HO H O

Elimination

HO OH
^ C - C lip i

o
7-deoxyaglycone
OH OH

o

HO OH

o
^C-CHpi-l

O HÔ
Qui none methide

O-

HO OH

OM
CHjOH

H^.O HO HO H II

Figure 11.

Electrochemical studies by Rao, Lown, and Plambeck
(1978).
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The electrochemistry of aqueous quinone solutions has been well
studied.

Reduction of the quinone under these conditions usually

occurs via a reversible, two-electron, two-proton transfer reaction
(K o lto ff and Lingane, 1952).

Rao et a l.

assigned the reduction

peaks around -0.6V to these processes.

The side chain carbonyl

groups were reduced by two irrev ersible

one-electron,

transfer

reactions

acetonaphthone.
-1 .3 V.

in

a manner

analogous

to

the

one-proton

reduction

These reduction potentials were around -1 .2

of
and

The authors f e l t that the cardiotoxicity depended on the

oxidative capacity of the chromophore and the elimination reaction
to

7-deoxyanthracyclinones

a fte r

the

anthracycline

had

been

enzymically reduced.
Molinier-Jumel,

Malfoy,

Reynaud,

and Aubel-Sadron

CNRS, Centre de Biophysique Moléculaire
used voltammetry,
mercury

ac polarography,

electrodes

and classical

with
They

and

daunomycinone.
structure

of

the
A ll

the

polarography on
DNA

compared daunomycin,

study

of

anthracyclines in aqueous solutions at pH's between 2 and 7.

daunomycin,

to

(1978)

in Orleans-Cedéx, France,

interactions

13-dihydrodaunomycin,

of

the 14-diethoxyacetoxy-

trans-3-aminocyclohexylcarboxylic
of

these

compounds

DNA but had vastly

stabilized

d ifferen t

ester

the

of

h elic al

antitumor properties.

They found that their electrochemistry was sim ilar to that described
by Rao et al (1978).

However, there was no correlation between the

electrochemically determined, in vivo. DNA-binding isotherm and the
antitumor a c tiv ity of these compounds.
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Pietronigro, McGinness, Koren, Grippa, Seligman, and Demopoulos
(1979)

from the Departments of Neurosurgery and Pathology of New

York University Medical Center reportedly obtained ESR signals from
aqueous adriamycin solutions buffered at pH's between 7.4 and 8 .9 .
They also compared some properties of 5-iminodaunorubicin in aqueous
buffers with those of adriamycin under sim ilar conditions.

The 5-

imino-derivative of adriamycin is neither mutagenic in the Ames test
nor as cardiotoxic as the parent compound; furthermore, i t did not
spontaneously form semiquinone radicals
concentration of adriamycin semiquinone
increased as the pH Increased.

in aqueous buffers.

The

radicals at steady state

The radicals that formed reacted

with oxygen in the solution; therefore, the quantity of the oxygen
consumed, as measured by an oxygen electrode, was taken to be the
radical

concentration

reported in pH 7.6
M e rritt

measured

generated

(10"% )

radicals.

hydroquinone group of
qui none

group

cyto to xicity.

in

on

solution. The concentration that

they

buffer corresponds with the concentration that
using quantitative

Pietronigro
the

et

anthracycline

the

a l.
8

C-ring played

Unfortunately,

the

ESR for microsomal ly
fe lt

-ring

that

both

the

and the adjacent

important

roles

authors mentioned neither

in
the

coproportionation-disproportionation e q u ilib ria occurring in aqueous
solutions

nor whether or

not

the radical species electro n ic ally

rearranged to produce the 7-deoxyadrimycinone and daunosamine under
anaerobic conditions.
In 1980, Feinberg (Note 2) at the University of Wisconsin in
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Milwaukee

performed

cyclic

voltammetry

on

aqueous

solutions at the request of Professor M cCarville.

In this study he

used a carbon paste electrode and three scan rates (u ):
and 200 mV per sec.

steffim ycin

50, 100,

Figure 12 shows the study he performed at pH 7.

The voltammagram shows two cathodic peaks labelled IC and IIC
at

a ll

scan rates

and an anodic

peak

labelled

!A.

The peak

potentials are:

Ep ( I C )

=

-0 .4 9 V

Ep (IIC )

=

-0.65V

Ep (lA )

=

-0.44 V

Unfortunately his data were in s u ffic ie n t for determining v/hether the
electrochemical
one-

or

processes corresponding to peaks IC and IIC were

two-electron

reductions.

He

also

indicated

that

the

irrev ersib le process occurring at -0.65 V (IIC ) was the adsorption
of steffim ycin onto the electrode.

The outstanding feature of this

study, when compared with sim ilar studies on adriamycin by Rao et
a l.

(1978a)

on a mercury electrode, was the a!)sence of the 7-

deoxyanthracyc1inone reduction peak.

Reduction of eith er adriamycin

or daunomycin on the mercury electrode in itia te d

an irrev ersib le

elim ination reaction to give the 7-deoxy-derivative and daunosamine
as noted e a r lie r .

Reduction of steffim ycin at the carbon paste

electrode eith er did not result in elim ination , or the reduction of
7-deoxysteffimycinone was the process occurring at -0.65 V ( II C ) .
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IIC
10

Current
(I'A)
5
0.45N PO4 pH 7.0
0

■5
0

- 0.2

-0.4

- 0.6

-

0.8

Volts
Curve
A

(l))scan rate; niV/sec
50

1Ô0
200

Figure 12,

Cyclic voltammetry of steffimycin (20pM) on a carbon
paste electrode. Feinberg (Note 2).
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In any case, the elim ination reaction, observed to be quantitative
upon reduction

of

the

appeared to be v ir tu a lly

anthracyclines

adriamycin

and daunomycin,

absent upon reducing steffimycin at the

carbon paste electrode at pH 7 under the conditions he used.
Pan et a l.

(1981) reported that aqueous solutions of anthra

cyclines treated with sodium borohydride became colorless.
Figure 13 sumnarizes much of the information (both enzymic and
nonenzymic) included in the previous two sections.

Nonenzymic

p

NADH

Flavoproteii

NAD
• Enzymic

NADPH

Figure 13.

NADP

A summary of some possible in tra c e llu la r states and
reactions of the anthracycline chromophore.
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Central to this diagram is the equilibrium mentioned before:
2AH*

AH,

The equilibrium constant fo r this reaction is not only pH-dependent,
but,

most

anthracyclines

lik e ly ,
lik e

anthracyc11ne-dependent
daunomycin

which

have

as

an

w e ll.

adjacent

For
quinone-

hydroquinone structure, there are th e o re tic a lly two e q u ilib ria :
DH4

DH2

:

2DH3*

daunomycin
hydroquinone

daunomycin

daunomycin
semiquinone

daunomycin

daunomycin
d iquinone

daunomycin
quinone-semiquinone

2DH-

As fa r as this investigator is aware, the equilibrium concentrations
of these species in in tra c e llu la r flu id s for various anthracyclines
are unknown.

Nevertheless, those e q u ilib ria have an obvious bearing

on an enzyme mechanism involving the anthracyclines.
however,

the

investigators

Apparently,

reviewed above (with the exception of

Kalyanaraman et a l . , 1980) examined neither th e ir kinetic nor th e ir
mechanistic data with these e q u ilib ria in mind.
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Statement of the Problem
This

investigation

McCarville

and

dependent,

nonflavin,

continued

Marshall,

who

the

had

microbial

work

p a r tia lly

reductase

begun

in

p u rified

from ^

1977
an

by

NADH-

hvdrophilia.

Using the p a r tia lly puriFied enzyme they had observed the reductive
cleavage of steffimycin to form 7-deoxysteffimycinone in anaerobic
conditions.

The

reaction

they

observed

is

shown

below.

S.

steffisburqensis due to its characteristic lush growth was chosen as
the source of a sim ilar enzyme.
The

following

determined:
reductions

the
it

properties
functional

catalyzed,

characteristics,

its

the
it

substrate

needed

to

be

contained,

enzyme

the

type

of

s p e c ific ity ,

its

physical

its j j i vivo function, and the types of compounds

inactivating or inhibitin g i t .
a re lia b le

of

groups

In order to address these unknowns,

assay and an isolation procedure had to be developed.

The description of these and other methods follows.

Steffimycin

NADH
O

o

-4 .

3 ^

HÔ

NAD 7-deoxysteffimycinone

I / o

Ô HÔ

O

HO

Ô HÔ
OH

steffose
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CHAPTER I I

MATERIALS AND METHODS

Enzyme Assays
In a ll cases, unless otherwise indicated, the buffers used for
the enzyme assays were eith er 0.1^ aqueous Tris-HCl (Fisher) or 0.1j[
aqueous sodium phosphate (Baker).

Throughout the remainder of the

M aterials and Methods section, the term buffer w ill refer to one of
these two systems.

An enzyme unit (EU) w ill represent the number of

micromoles of NADH turned over by the enzyme per minute (min).
Anaerobic Assays
Chromatographic (O rigin al)
This assay, used o rig in a lly by McCarville and Marshall (1977)
and to a lim ited extent in this work, consisted of a 0.9 ml solution
of buffer at pH 7.0 made to 5.7mM in disodium NADH (BoehringerMannheim, lo t number 158106), S.lmM in beta mercaptoethanol (gme,
Eastman-Kodak, lo t number S5D), and 2.4mM in steffimycin (U-20661,
8598-JNB-35-2) in buffer at pH 7 .0 .
solution to make the sample volume
and blank started the reaction.
evacuation

of

the

space

1

Addition of s u ffic ie n t enzyme
ml and deoxygenation of samples

Deoxygenation was accomplished by

above

the

sample

followed

by

re-

47
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equ ilibration of the sample with oxygen-free nitrogen gas (Burdox); .
this process was repeated twice.
glass tubes f it te d

The samples were contained in 5-ml

with a silicone-rubber stopple.

buffer added in place of the enzyme solution.
blank were incubated at 370C for 3 hours.

The blank had

Both samples and

Each was extracted with 1

ml of eith er methylene chloride (Burdick and Jackson) or chloroform
(Mal.linckrodt).

The extracts were compared to each other and to the

blank using eith er hplc or t i c .
Chromatographic (Current)
The anaerobic assays used presently were run in pH 6.0 buffer
containing 0.8mM NADH and 0.4mM steffim ycin (S ).

Oxygen was removed

from the assay solutions by sparging each with helium.

They were

incubated at room temperature in a glove bag under an oxygen-free,
nitrogen

atmosphere.

The blank was made up with

volume of buffer in place of the enzyme solution.
the assay and blank
nitrogen
bath.

an equivalent

Aliquots of both

solution were removed at intervals from the

atmosphereami

Frozen

immediately in an acetone-dry ice

The samples were thawed and immediately injected onto an hplc

column and eluted with a c a re fu lly degassed solvent system.
Polaroqraphic
Theenzymic

reduction

chamber of a Model
analyzer.

The

reaction

was run

in

the

electro lyte

364, Princeton Applied Research Polarographic

i n it i a l

concentrations

of

NADH and

S

in

the

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

49
electro lyte

(pH

respectively.

O.IJ^

phosphate)

over

it

for

the

about four minutes.

electro lyte

surface

conditions during the polarographic
done

in

the

(Bethlehem,

were

0.4

and

0.2mM

Oxygen was purged from the electro lyte by bubbling

helium through
directed

6.0;

d iffe re n tia l

t r ip le

pulse

d is tille d )

A stream of helium

maintained

analysis.
mode

electrode.

on

the

anaerobic

The analyses were
a

dropping

The voltage

mercury

(versus a

standard, s ilv e r/s ilv e r chloride h a lf-c e ll) was scanned over a range
from 0 to a minus 1.5 volts (V ).
monitor

the

progress

of

the

repeated at regular in te rv als.

Tfie scan rate was 2.0 mV/sec.
reaction,

the

voltage

scans

To
were

The changes in the concentration of

both NAD and S corresponded to the peak heights of the output at the
reduction potential of each species (-0 .8 9 V for NAD and -0.5 and
-1 .0 V for S).

The recorded output was the d iffe re n tia l of the

change in the current (microamperes,p A) as the voltage was scanned.
In addition,
removed

at

chloroform.

1-ml

regular

aliquots of the electro lyte
intervals

and

extracted

solution were

with

1

ml

of

The extracts were evaluated by t ic or assayed by hplc.

Spectrophotometric Assay
The composition of the assay solutions used in the anaerobic
spectrophotomebric assay was sim ilar to that used for the current
anaerobic chromatographic assay described previously.

The sample

solutions contained NADH, S, and enzyme; the blank contained a ll but
S.

The assays were run in 3-ml stoppered cuvettes having a 1-cm
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pathlength.

Both

assay solutions were

deoxygenated by repeated

evacuation and regassing with an oxygen-free in ert gas.

The course

of the reaction was followed by monitoring the change with time in
the absorbance of the sample versus the absorbance of the blank at a
wavelength of 340 nanometers (nm) at room temperature.
equivalent

to

the

rate of

NADH consumption

reduction as affected by the anthracycline.

This was

during the

enzymic

The in it ia l rate was

equated with the slope of a tangent to the absorbance change curve
over only the f ir s t
enzyme
mixture.

solution

or

5 minutes of the reaction
NADH solution

a fte r eith er the

had been added to

the

assay

The instrument used to monitor the absorbance changes was

e ith er a Cary 118 or Hitachi 100-60 spectrophotometer.
Aerobic Assays
Standard Assay
Standard assays were run in a sim ilar fashion to the anaerobicspectrophotometricassays,

except

that

solutions were equilibrated with a ir .

the

sample

and

blank

These were a ll run at ambient

pressure and temperature (since the temperature dependence of the
rate was shown to be minimal).
for

any procedure

requiring

This assay was the assay of choice
numerous,

rapid

assays

(McCarville,

1977).
Electron spin resonance
A ll assays to determine the presence of free radicals were done
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on a Varian

E-9

cav ity.

sample solutions were contained in 0.2-ml ca p illa ry

A ll

tubes.

spectrometer

fit te d

with

The c a p illa ry tubes were tig h tly

an E-232 dual

sample

stoppered with beeswax.

The composition of the blanks and sample solutions was sim ilar to
those of the o rig in al chromatographic anaerobic assay, although no
attempt was made to make the samples anaerobic.

The assays were run

at room temperature (M e r r itt, Note 4 ).
Oxygen electrode
A ll experiments were performed using a Yellow Springs Model 53
oxygen electrode.

The temperature was maintained at 25-280C with a

Haake, Type FE constant-temperature bath connected to the Yellow
Springs Model 5301 bath assembly.
using a Fisher Recordall 5000.

The electrode output was followed
The sample volumes were usually 5

ml, and the composition was sim ilar to that used in the standard
assay.

The addition of S (5mM in dimethylformamide [DMF]) to the

sample

solution

reduction

of

S.

in

the
The

electrode
sample

chamber

solutions

started

contained

concentrations and varying amounts of enzyme solution.

the

enzymic

varying

NADH

The oxygen

consumption rate affected by S was the rate observed upon addition
of S minus the in trin s ic rate without steffim ycin.
Diaphoretic a c tiv ity
The diaphoretic a c tiv ity w ill be defined as the rate of enzymic
oxidation of NADH in the absence of S.

This was measured using
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eith er

the

anaerobic

electrode assay.

or

standard

aerobic

assay

or

the

oxygen

The assay solutions were sim ilar to those used for

the standard assay except that S was not included in the mixtures.
Specific a c tiv ity of the enzyme
The

specific

ra te ,

a

measure

of

the

determined by the spectrophotometric assays.

enzyme

p u rity ,

was

I t was calculated by

subtracting the diaphoretic a c tiv ity from the concentration change
of NADH in the presence of S and dividing by the amount of enzyme
(mg) used in the assay.

A

This can be represented symbolically as
[NADHlg

_ a [NADH]\

A t ____________A t

I

«■t Ve /
The term

a

[ NADH] g / A t represents the change in NADH concentration

(as measured by the change in. absorbance at 340 nm) per minute; the
term

a

[NADH]/ At is the diaphoretic a c tiv ity ;

of the assay solution in lit e r s ;

[P^

equals the volume

is the concentration of the

protein solution being assayed in g per l it e r ; Vg is the volume of
the

enzyme

solution

in

lite r s

being

assayed;

and,

f in a lly ,

v

represents the specific rate in fractional moles per minute per gram
of protein.
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Protein Assays
Three types of protein assays were used during the course of
these studies:

measurement of the uv absorbance of a solution, the

Lowry

and

assay,

measurements were

disc-gel

electrophoresis.

done on eith er

of

the

The

two

absorbance

spectrophotometers

mentioned previously and at room temperature.
UV Absorbance
The absorbance of solution
protein concentration.

at 280 nm is

a function of the

This was the assay of choice fo r a ll rapid,

repeated determinations of protein concentration.
Lowry Assay
The method of Lowry, Rosebrough, Farr, and Randall (1951) was
used with

minor variations.

Either

bovine

serum albumin

(BSA,

Pentax, fraction V) or bovine globulin (Bio Rad) was used as the
protein standard.
Disc-gel Electrophoresis
The basic method of Ornstein and Davis was used for analyzing
the

protein

electrophoresis.
3.

content

of

various

isolates

by

disc-gel

The power supply was a Heath Regulated Model PS-

The following stock solutions were used to make the g elling

mixture:
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Solution

A;

acrylamide,

BIS

(30:0.8)

-

30%

acrylamide

(Eastman, lo t number 5521) and 0.8% N, N' methy1ene-b1s- acry1ami de (K
and K Labs, lo t number 7498).
Solution B:
Solution
793044).

1.5M Tris-H C l, pH

C:

8

.8 .

10% ammonium persulfate

(Fisher,

This solution had to he made fresh weekly.

lo t

number

The rest of

the stock solutions could be stored at 40C in dark glass containers
for several months.
Gel formation
The stock solutions were mixed according to the sequence and
quantities shown in Table 7 to make gels containing 7.5% acrylamide
and degassed under a vacuum for about 3 minutes.
Table 7
Composition of 7.5% Gels for Disc-Gel Electrophoresis
M aterial

Quantity (ml)

Solution A

5

Solution B

2.5

N ,N,N',N '-tetram ethyl ethylene
diamine (TEMED, Baker; lo t number 317201)
Solution C
Water

0.007

0.1
12.4

The quantity of gel made according to Table 7 was su fficien t to
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produce about 10 gel columns (0.45 by 10 cm).

A fter f i l l i n g each

column to within 1.25 cm of the top with degassed gelling solution,
about

0 .1

gel.

A fter polymerization (about 1 hour) the water was replaced by

ml of d is tille d

electrophoresis b u ffer.

water was layered onto the top of the

The gels thus formed were stored at least

12 hours at 4°C before use.
Electrode buffer
The buffer in the electrode chambers was

6

g/ 1 of Tris-HCl and

28.8 g/1 of glycine adjusted to pH 8.3 with 2^ T ris .
Sample application
About 100 yg of each protein band mixed with 50% sucrose and
0.5% bromthymol blue (Bio Rad, control number 14459) was applied to
the top of each column.

The space above the sample was f il le d with

electrode b uffer.
Running conditions
The columns were pretreated by electrophoresis for about 30 min
at

0.5

catalyst.

mA of

current

per

gel

column

to

remove

the

residual

The sample solutions were applied to the top of each gel

column and electrophoresis was begun by applying s u ffic ie n t voltage
across the ends of columns to produce 4 mA of current per column.
Other than maintaining the low current flow during the course of the
electrophoresis, no further temperature control was used.

The gels

were removed from the glass tubes a fte r the run and were fixed in
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12% trichloroacetic acid (TCA, Mallinckrodt; lo t number KHEL) prior
to staining.
Gel staining
The method used for staining the protein bands in the gels was
sim ilar

to

Zaccari

(1967).

that

described by Chrambach,

R e is fie ld ,

Wyckoff,

and

The gels were soaked in 10% TCA saturated with

, Coomassie B r illia n t Blue R-250 (Bio Rad, control number 12796) fo r
about

1

hour.

Oestaininq
The

stained

gels

were

placed

in

the

fix in g

solution

for

diffusion destaining.
Enzyme Isolation and P u rificatio n
The isolation steps from cell harvest to cfe w ill be referred
to

as

the

isolation.

Figure

14 outlines

the

iso la tio n .

The

pu rificatio n denotes the sequence of steps necessary to prepare a
nearly homogeneous enzyme concentrate from the cfe.
outline of the p u rific a tio n .

Figure 15 is an

A ll enzyme isolation and p u rificatio n

steps were done at 4°C unless otherwise indicated.
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M a te r ia ls

Q u a n t it y

W hole b e e r

250 1

C o rn e n t s

F iltr a tio n
D is c a rd F i l t r a t e

F re e z e D ry in g

NaN]
PTSF
EDTA
DTE

F re e z e a t - 1 4 0 * 0
Vacuum <6 m i l l i t o r r
D is c a rd s u b lim a te

M illin g

0 . 8 ; j S c re e n , R. T .

R esuspension

B lend f o r — 10 m in
@4*0

l

2.0 mg/1
1 7 .3 m g/1 >— h
1.0 m g/1
3 8 .6 mg/1
20 m l/g c ^ l l s

C e n t r ifu g a tio n

1 8 ,0 0 0 rp m , 4 * 0 , 1 h r
D is c a rd p e l l e t

Figure 14.

Enzyme iso la tio n .
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Sorption

0 .5 1
100 g/1 cfe

_> D is ca rd in a c tiv e spent
—W
I

pH 7 .0 b u ffer
pH 9 .0 b u ffe r + l.OM NaCl

Wash

I

Elution

j

^ D iscard in a c tiv e wash

Concentration

I Concentration
Q O p t io n a l )

Gradient

50 p s i, 4*C
YM'IO Amicon Membrane
♦ Discard u l t r a f i l t r a t e

As above

♦ Discard u l t r a f i l t r a t e

70 ml/1 c f e

A ffig e l Blue

# |A ffin ity Sorption]
> Discard in a ctive spent

pH 7.0 b u ffer

pH 7 .0 b u ffer
pH 7.0 b u ffe r + 2 .OH NaCl

_ i|

Elution

J

IConcentration I

Discard in a ctive wash
Gradient

As above
», p {;card u l t r a f i l t r a t e

Figure 15.

Enzyme p u rific a tio n .
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Isolation
Cell harvest
Whole fermentation broth that ranged In volume from a shakeflask

(200 ml) to 2 0 - lit e r tanks was vacuum-filtered over a fa s t-

flowing,

glass-fiber

appropriate

size

filte r

disc

(Schleicher

and Schuell)

supported by a Buchner funnel.

of an

The retained

mycelia were resuspended in about 10% of the o rigin al broth volume
of deionized water and r e f ilte r e d .

This wash was repeated.

The

2 5 0 -lite r fermentations were f ilte r e d on an 18-inch, Sperry Type 47,
plate and frame f i l t e r press.
filte r

cloth.

water through i t .
at

The mycelia were retained by a canvas

The mycelial pad was washed by recycling deionized
The washed pad was eith e r freeze-dried or stored

4 0 c.

Lvophilization
The c e ll
pieces

pad from the harvest was broken into

and spread

onto

a covered,

about 2-cm^

30 by 90-cm stainless

steel

tra y .

The tra y was clamped onto a shelf of a V ir tis 100-SRC freeze

dryer.

The product was frozen at -35°C and dried under 6 m illit o r r

of absolute pressure as the shelf temperature was automatically,
slowly (over 12 hours) raised to room temperature.
M illin g
Freeze

dried

mycelia

were

broken

into

subcellular-sized
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fragments

by

subjecting

them to

a single

Creston, Type DFH-48, hammer m ill.
that

fed

into

a r a d ia lly

fluted

pass

through

a Glen

The m ill consisted of a hopper
m illin g

chamber about

cm in

8

diameter within which 4 pendulous vanes spun about a common axle.
The m illed product was blown from the chamber through an e x it port
fit te d

with an 0.8 micron screen.

The m illin g was done at room

temperature.
Sonification
Sonification

was

an infrequently

used

method

of

cell

disruption; however, when i t was used, about 50 mg of freeze-dried
cells

per

m illilit e r

were slurried

in

the extraction

buffer.

Extraction buffer consisted of buffer plus some additives to in h ib it
bacterial

growth,

proteases.

These additives were:

Kodak;

preserve

lo t number E-3A);

oxido-reductases,

and

in h ib it

2.0 mg/1 of sodium azide (NaN^,

17.3 mg/1 of para-toluene sulfonic acid

(pTSF, Aldrich; lo t number 060-687); 38.6 mg/1 of d ith io e ry th rito l
(DTE,

Aldrich;

lo t number

122867);and

1.0

ethylenediaminetetracetic acid (EDTA, Aldrich;

mg/1

of

lo t number 071137).

Throughout the remainder of this dissertation the extraction buffer
w ill mean buffer containing these additives.
this

slurry

were sonified

for

3 to 5 min

Disrupter 350 set at maximum power.

F ifty-m l aliquots of
with

a Branson Cell

The aliquots were ch illed to

4°C in an ice bath during sonification to remove the heat generated
by the process.
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C e ll-fre e preparation
Fractured cells were suspended in s u ffic ie n t extraction buffer
to produce a protein concentration in solution of 30 to 50 mg/ml.
The resulting suspension was centrifuged at 10,000 times g ravity in
eith er

a Servall

high-speed

SC-20 or Sorvall

centrifuge

remainder of

this

fo r

RC 2-B (Dupont)

30 minutes

dissertation,

at

4^0.

refrig erated ,

Throughout

the c e ll-fr e e extract (cfe)

the
w ill

refer to preparations obtained in this manner.
P u rification
P recipitation
In

most

but

not

a ll

cases

a precipitation

step was used.

Enough ammonium sulfate (Mallinckrodt) was added to the cfe to bring
the resulting

solution

to 40% of saturation

in ( ‘iH^)2 S0 4 .

The

protein p recipitate that formed was aged at 40C for about one hour
then centrifuged as described in the previous section.

The p e lle t

was

assay,

resuspended

in

b u ffer,

discarded i f inactive.

assayed by

the

standard

and

S u fficient (NH^)2 S0 4 was slowly added to the

supernatant to make the s a lt concentration 60% of saturation.

The

precipitate

The

was aged,

centrifuged,

inactive supernatant was discarded.

and assayed as before.

For dialysis the precipitate

was resuspended in about 15% of the cfe volume of extraction buffer.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Dialysis
Before use, Visking cellulose dialysis tubing (Union Carbide)
was presoaked fo r eight to twelve hours in warm sodium bicarbonate
solution and then washed with several changes of deionized water.
The solutions to be dialyzed were enclosed within bags made from the
pretreated tubing and equilibrated fo r 24 hours with 2 changes of
buffer

the

volume of

which was usually

6 -8

times that

of

the

solution being dialyzed.
DEAE-cellulose chromatography
The starting material for the DEAE-cellulose (Whatman, DE-32)
chromatography

was

eith er

the

fra ctio n or the centrifuged cfe.
glass column pre-equilibrated

dialyzed

(NH4 ) 2 S0 4

precipitate

This was fed onto a 2.5 by 25-cm

with buffer.

The charged bed was

eluted with a sodium chloride (NaCl, M allinckrodt; lo t number KEYB)
gradient made from 1.0 1 o f buffer and 1.0 1 of buffer made l.OM in
NaCl.

The spent, wash, and gradient eluates were collected into 15

to

ml fractions

20

enzyme a c tiv ity ,
th e ir

enzyme

that were assayed for

and conductivity.

p u rity .

The

protein concentration,

They were pooled according to

resulting

enzyme

rich

pool

was

concentrated to about 7% volume.
Concentration
Concentration of protein solutions was done u tiliz in g one of
two u ltr a f ilt r a tio n

systems:

the f ir s t

and most frequently used
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were s tirre d ,

p re s s u re -u ltra filtra tio n

c e lls

(Amicon) f it te d

with

Amicon YM-10 u ltr a f ilt r a tio n membranes (nominal molecular mass cut
o ff 10,000 daltons).

The other system was the M illip o re immersible

CX-10 membrane, vacuum u l t r a f i lt e r
daltons).

(molecular mass cu t-o ff 10,000

A vacuum is applied to these small, thimble-shaped units

and the u l t r a f i lt r a t e

is forced into them under ambient pressure.

These units were used prim arily for concentrating <10-ml samples.
Gel f ilt r a t io n
The concentrate from the DEAE chromatography was applied to the
top of a 5 by 90-cm Sephadex G-150 (Sigma, lo t number 96C-0128) bed
and developed with buffer at
into 19-ml fra ctio n s .

~12

m l/hr.

The efflu en t was collected

The bed was precalibrated with dextran blue

(Pharmacia) to determine the minimum exclusion volume and with a
solution

of

10 mg/ml

BSA,

10 mg/ml pepsin (Aldrich,

lo t number

071657) and 5 mg/ml lysozyme (Calbiochem, lo t number 400062) in 5 ml
of buffer to calib ra te the exclusion volume dependence on molecular
weight.

Calibration

curves

were

constructed

by

plotting

logarithm of the molecular weight against the elution
exclusion volume units.
enzyme a c tiv ity

the

volume in

The eluate fractions were assayed fo r both

and protein concentration and pooled according to

the enzyme p u rity .
A ffin ity chromatography
The column made from A ffig e l Blue (BioRad), a Cibachron Blue
dye covalently bound to sepharose, was 2.5 by 30 cm.

The procedures
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used were variations of those described by Stellwagen
Weber

(1979)

proteins.

fo r

using

immobilized

Cibachron

Blue

(1977) and

in

purifying

The gel f ilt r a t io n eluate pool was applied d ire c tly to

the column which had been pretreated with one bed volume (bv) of 9M
urea and pre-equilibrated with b uffer.

The column wash was 2 bv of

b uffer, and the eluent was a gradient formed between
buffer and buffer made l.OM in NaCl.

1

bv each of

The eluate fractions (10-ml)

were collected and assayed for both protein concentration and enzyme
a c tiv ity .

T!ie

fractions

were pooled

according

to

th e ir

enzyme

purity and the enzyme-rich eluate was concentrated to about 5% of
its original volume.
Isolation Studies
Developing
optimization

a

successful

studies

techniques.

This

and

section

enzyme

isolation

evaluating
w ill

describe

scheme

alte rn ative
a few of

required
isolation

these.

The

purified enzyme was used for a ll the studies below unless otherwise
indicated.

'

Preparative iso electric focusing
The technique used was sim ilar to that used by Righetti
Drysdale

(1976).

A

50-ml

cfe

prepared

by

sonification

and
and

centrifugation of fresh cells suspended in deionized water was added
to about 75 ml of preswollen Sephadex G-75 (Pharmacia).

Two ml of

40% LKB c a rrie r ampholytes (pH range 3.5 to 10) and 0.2 ml of

3

ME
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were also added to this mixture.

The resulting slurry was poured

into an 8.5 by 18.5 cm electrofocusing tra y .

Excess moisture was

removed by placing the tray below a hair dryer.

Electrophoresis-

paper wicks were placed at each end of the tra y and saturated with
eith er

IN. su lfu ric

(NaOH, anode).

acid

(H2 SO4 , cathode)

or IJN sodium hydroxide

Electrofocusing was done under a constant power of 2

watts provided by an E.C. Apparatus power supply model EC-400 fo r 12
hours at

4°C.

about 15

equally spaced zones 0.7 cm wide and each fra ctio n

At the end of that time the gel

slurried

in

filte r e d

through acoarse,

a c tiv ity ,

and protein concentration of each f ilte r e d fra ctio n was

10 ml

of double d is tille d

water.

was divided into
was

Each slurry was

sintered-glass p late. The pH, enzyme

measured.
A ff in it y support screening
Four Dyematrix

(Amicon)

a f fin ity

chromatography mini-columns

were used to test the binding of the enzyme to various adsorbents of
th is type.
following
Geigy),
B).

Three of the columns contained 1 ml each of one of the
dyes bonded to

Procion

sepharose:

Red HE3B ( IC I) ,

Cibachron Blue F3GA (Ciba-

and copper phthalocyanine

The fourth contained 1 ml of the sepharose m atrix.

of a G-150 eluate was applied to each column.
2.0 ml of buffer and eluted with Ij^ NaCl.
eluates

were collected

into

pools

(Blue

About 1 ml

A ll were washed with
Spent feed, washes and

and assayed fo r

both

protein

concentration and enzyme a c tiv ity .
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A ffin ity chromatography fed with cfe
The a f fin ity chromatography column was sim ilar in dimension and
packing m aterial

to

that

described before.

The material

to he

chromatographed, however, was a cfe made by centrifuging a slurry of
m illed cells in extraction buffer

(1

g/ 1 0 m l).

A ffig e l elution with the coenzyme
The gel f il t r a t io n eluate (about 1 ml) was applied to a small
0.6 by 7-cm A ffig e l blue column.

The charged column was then washed

with 1.5 ml of buffer and eluted with 1.5 ml of 1.3mM NAD.
eluate was followed by a 1-ml buffer wash.

The

The spent, wash, and

eluate fractions were assayed for enzyme a c tiv ity using the standard
assay.
pH versus enzyme extraction
To determine the effe c t of the buffer pH on the extraction of
the enzyme from m illed,

freeze-dried c e lls ,

tion buffers at pHs 4 through

8

100

ml each of extrac

were used to disperse about 5 g of

fractured cells in a Waring blender and were then centrifuged.

Each

sample was assayed for enzymic a c tiv ity .
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Enzyme Characterization
The techniques described below

used to determine some of

the characteristics of the isolated reductase:
pH Optimum
The

purified

enzyme

was

assayed

using

both

the

oxygen

consumption and the spectrophotometric NADH consumption assay at
nine pHs from pH 3 to pH 9 in O.IN^ phosphate or Tris buffers.

The

maximum NADH or O2 turnover rate at the same temperature, substrate
and cofactor concentration was taken to be the pH optimum for the
enzyme.

A ll determinations were done at room temperature.

Kinetics
Michaelis-Menten kinetics were assumed.

The standard assay v;as

used to determine the e ffe c t on the rate caused by varying the
substrate concentration while the cofactor (NADH) was at a concen
tra tio n assumed to be saturating fo r the enzyme.

In addition the

cofactor concentration was varied as the substrate was maintained at
saturation.

and

fo r each were determined from Lineweaver-

Burk plots of the data obtained.

A ll determinations were done qt

room temperature.
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A lternate Substrates
A ll purchased compounds trie d as enzyme substrates were used as
they were received from the supplier without fu rth e r treatment or
p u rific a tio n .

The anthracyclines daunomycin and adriamycin were

g ifts from NCI; 7-OMEN and 7-deoxysteffimycinone were g ifts of Dr.
Paul Wiley of The Upjohn Company.

Nogalamycia was prepared in the

Fermentation Research and Development Unit of Upjohn.
and C were purified by eith er classical
high-performance,

preparative

liquid

Steffimycin B

column chromatography or
chromatography

and

c ry s ta lliz a tio n .
The standard assay was used to screen most of the compounds
listed for a c tiv ity and they were added to the assay solutions in
the

place

of

S at

a

concentration

of

eith er

100 u M or

that

corresponding to th e ir saturated aqueous solutions.
Anthracyclines
Several anthracyclines were trie d as substrates.
were 10-deoxysteffimycinone;

nogalamycin;

7-OMEN;

Among these

adriamycin

(NSC

number 123127); and daunomycin (NSC number 82151).
Dyes
In addition a few anthraquinone dyes were used; these include
Cibachron Blue (Sigma Chemical Co., lo t number 39c-0509); methylene
blue
0390);

(A llied

Chemical

purpurin

Corporation);

(Matheson,

DCIP (Sigma,

lo t number 78C-

Coleman and Bell [MCB] Manufacturing
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Chemists, lot number S-3M-13); and a liz a rin (MCB).
Others
Other

non-anthraquinone

substrates

tested

include

menadione

(Kodak); oxalacetic acid diethyl ester (Sigma, lo t number 37c-0383);
quinic acid (Aldrich Chemical Co., lo t number 081977); shikimic acid
(National Biochemical Corp.); and rib o flavin (Kodak, lo t number A5B).
Cofactors
NADPH (200 tjM, Sigma; lo t number llC-7310) was substituted in
the standard assay fo r NADH.
Inhibitors
To determine some of the compounds and conditions inhibitin g
the reductase, several types of studies were done.
Preincubâtion
The

enzyme

was

incubated

with

various

steffimycin in buffer fo r 1 hour at RT.

concentrations

started by the addition of NADH to the assay mixtures.
rate

was measured

spectrophotometrically

of

The enzyme reaction was
The in it i a l

and compared with

obtained when the assay was run in the standard v/ay:

that

i . e . , when the

enzyme was added to start the reaction.
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Dissolved oxygen
The

enzymic

reduction

rate

was

compared

concentrations: ~860uM, 260jjM, and <1.0uM.
buffer

containing

following gases:
purified

at

200 uM NADH 'were equilibrated
oxygen (Linde),

a ir ,

enzyme prep and stef Fimyc in

three

oxygen

Three 10-ml samples of
with one of the

and helium (Linde).

The

in DMF were added, and the

in it i a l rates of disappearance of NADH were compared.
Flavin suicide substrates
Five-ml cfe samples were incubated fo r 1 hour at RT and pH 7
with one of the following:

1-dimethyl amino-2-propyne (Aldrich, lot

number

N-propargyl

040497);

N-methyl

benzyl amine

(Aldrich,

number 092987); a lly l amine (A ldrich, lo t number 7018CE).
concentration of each in h ib ito r was
sample were percolated

0.05j4.

About 0.5 ml of each

through a G-10 (Pharmacia)

column (0.8 by 20 cm) and eluted with b uffer.

lot

The fin a l

gel f ilt r a t io n

A 0.5-ml sample of

the untreated cfe starting m aterial was desalted in a sim ilar way.
The protein-containing

eluates were pooled,

using the standard assay.

assayed and compared

The gel f ilt r a t io n column was washed with

4 bv of buffer between each charge.
Other
A number of

compounds were tested

for

th e ir

enzyme a c tiv ity as measured by the standard assay.

effe ct on the
They were added

to the assay mixture in concentrât ions from 10 to 100uM.

Among the
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compounds

used

w arfarin,

barbital

daunomycin,

were:

EDTA,
(Fisher,

ascorbate

pTSF,
lo t

and Triton

p(liydroxymercuri)
number

X-100

792300),

(BioRad,

benzoate,
adriamycin,

control

number

20430).
UV-Visible Spectra
The absorbance as a Function of the wavelength was determined
for the a ffig e l eluate concentrate using the Hitachi spectrophoto
meter.

The wavelength

was

scanned

from 600

concentration of the enzyme solution used was
length of the spectrophotometer cells was

1

to
0

210

nm.

The

. 1 % and the path-

cm.

Iso electric Focusing
The preliminary isoelectric focusing was done on Ampholine PAG
plates of pH 3.5 to 9.5 (LKB, lo t number 377).
were done on PAG plates of pH 4.0 to 6.5
power supply was a Heath Model PS-3.

Final determinations

( lo t number 041).

The

A ll electrofocusing was done

at 1 to 2 watts of power fo r 10 to 12 hours and RT as recommended by
Hoyle (1979).

The plates were run horizontally according to methods

described by Righetti and Drysdale (1976).
Electrode solutions
For pH 3.5 to 9.5 plates the electrode solutions were O.lJi NaOH
for the cathode and O.lJi H2 SO4 fo r the anode; for pH 4.0 to 6.5
plates they were O.ljjl 3 -alanine fo r the cathode and 0.1^ glutamic
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acid and 0.5^ o-phosphoric acid fo r the anode.

Whatman f i l t e r paper

wicks soaked in these solutions were applied to opposite ends of the
gel p late.
Sample application
Protein samples of about 100 pg were applied to the g el.
solutions

were applied

to

the

gel

about

These

cm apart at varying

2

distances from the anode wick.
pH measurement
A fter electrofocusing the pH gradient was determined by cutting
a s trip paralle l to the applied voltage and
of the gel p late.

1

cm wide from one end

The s trip was further subdivided into 1-cm pieces

that were homogenized in tubes containing about
d is tille d water.

2

ml of double

The pH of each tube was measured.

Gel staining
The remainder of the gel was treated according to the following
procedure:
a.

Immediately a fte r electrofocusing was completed the PAG

plate was immersed in fix in g solution for
b.

1

hour.

The fixed plate was immersed in destaining solution fo r 10

minutes.
c.

The pre-equilibrated plate was stained in staining solution

fo r 10 "minutes at 60°C.
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d.

The plate was destained by both soaking the gel in several

changes of destaining solution and wiping the gel surface with a
cotton swab (Cheesebrough-Ponds In c .) soaked in destaining solution.
Fixing solution
The fix in g

solution

was 70% aqueous methanol containing 3%

su lfo salicy clic acid (Aldrich, lo t number MB 100377) and 12% TCA.
Staining solution
The protein

stain was 1.2% of Coomassie Blue in destaining

solution.
Destaining solution
The destaining solution was 75% aqueous ethanol containing

8%

acetic acid.
SOS Gel Electrophoresis
The buffer system of Laemmli and Maizel

(1970) was used for

sodium dodecylsulfate (SOS) gel electrophoresis.

The power supply

and the gel solutions used were the same as those described e a r lie r .
Gel formation
The

solutions

were

quantities shown in Table
solution

as

described

mixed
8

.

according

to

the

sequence

and

About 10 gels were produced from this

e a rlie r

for

the

standard

disc-gel
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electrophoresis method.
Table

8

SOS Gelling Mixture

Material

Quantity (ml)

Solution A

6

Solution B

2.5

10% aqueous SOS (ICN, lo t number 5268)

0.2

TEMED

0.007

Deionized water

11.2

Solution C

0.1

Sample preparation
Protein samples (up to 1 mg) were suspended in 0.05^ Tris HCl
buffer

(pH

6 .8

) containing 1% SOS, 0.7% of

gME, 0.5% bromthymol

blue, and 10% glycerol, and heated for 2 minutes at 100°C.
Electrode buffer
The electrode buffer contained

6

g of T ris , 28.8 g of glycine,

and 10 ml of solution C per l i t e r of water.
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Running conditions
The conditions used for the electrophoresis experiments were
those described for standard disc-gel electrophoresis, but about

2

to 3 mA per gel column were used.
Protein Visualization
The

fix in g ,

staining,

and

destaining

solutions

were

those

described for the iso electric focusing gels.
U1tracentifuqation
A Beckman Model LS-G!) ultracentrifuge f it te d with a fixed angle
rotor

was used to

eluates.

tre a t

samples of both cfe's

and active DEAE

The samples were subjected to about 100 K times gravity

for about 90 min at 4°C.
Properties of Steffimycin and Its Derivatives
Some

of

information

the
about

following
the

studies

aqueous

were

chemistry

done
of

to

both

obtain

more

anthracycline

substrates and products formed by the isolated microbial reductase.
Aqueous S o lu b ility
The solids content oF the following solutions were compared:
0.1]^ phosphate buffer

(pH 6 .0 );

a saturated S solution

in this

buffer;

and a saturated solution of 7-deoxysteffimycinone in this

buffer.

The saturated solutions were made by agitating an excess of
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the c ry s ta llin e compound in about 10 ml of buffer for 0.5 hours at
500C.

The slurry was filte r e d through a coarse sintered-glass plate

a fte r the solution cooled to RT.

Samples of about 5 ml

under

atmosphere at

900C then desiccated under high

vacuum at lOOOQ fo r 20 minutes.

A fter cooling^ the samples were

a nitrogen

were dried

weighed.
T itra tio n
S u ffic ien t S in DMSO (Eastman, lo t number B6 A) was added to
d o u bly -distille d water to make the concentration 425 wM.

A 100

m ic ro lite r Hamilton syringe was used to t it r a t e the 10-ml S solution
with 20_mM NaOH.
recorded.
the

A fter each addition of base the solution pH was

Several determinations were made.

pH recorded

a fte r

the

addition

of

The pK^ was equated to
2.13

ymoles

of

sodium

hydroxide.
Polaroqraphy
Polarographic studies according to Knobloch (1971) were done at
several pH's and at various S concentrations.
was

described

e a r lie r

in

this

section.

The apparatus used

The S solutions

were

analyzed not only in the d iffe re n tia l pulse mode but also in the
standard dc-polarographic mode.
done

on

adriamycin,

Similar polarographic studies were

daunomycin,

nogalamycin,

7-OMEN,

and

steffim ycin C.
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Fluorescence Spectra
The excitation and emission spectraoF about 25p M S solutions
inethyl

acetate

were

obtained

using

a

Perkin Elmer

204

A

fluorescence spectrophotometer.
Excitation spectra
The excitation spectrum was determined by measuring the to ta l
lig h t emitted at a ll

wavelengths from a sample illuminated by an

orthogonal beam varying in wavelength from 250 to 450 nm.
Emission spectra
The emission spectrum was obtained by measuring the amount oF
lig h t at wavelengtfis between 500 and 700

nm emitted as the sample

was irrad iated by an orthogonal beam of eith er 320 or 373 nm.

m
Two types of t ic systems were used.

These were;

Polar stationary phase
Whatman HPTLC plates with a 5 micron ( y)
phase were most frequently used.

s ilic a

stationary

From 1 to 50 yg of the anthra

cyc line mixtures were applied and the t ic plate was then developed
with ethyl acetate.

The chromatograms were photographed using the

fluorescence of the anthracyclines under long wavelength uv lig h t.
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Reverse phase
In this mode the plates used were Whatman KCjg plates with a
bonded octadecylsilane

(ODS)

s ilic a

layer.

These

with a solvent system composed of 60% methanol,

were developed

30% water, and 10%

methylene chloride.

About 20 y g of the anthracycline was spotted at

the

chromatograms

o rig in .

The

v/ere

photographed

under

long-

wavelength uv lig h t as described.
Hplc
The most frequently used hplc system is outlined below.

The

instrument was a Vista 401 system that included an enslaved Varian
5060 liqu id chromatograph and a Varichrome continuously variable,
u v-visib le,

liquid

chromatography detector.

The conditions

used

were :
mobile

phase:

a c e to n itrile

(Burdick

and Jackson),

doubly-

d is tille d water, and tetrahydrofuran (THF) in a ra tio of 50:45:5,
stationary

phase:

Whatman

ODS

10

(0.3

x

25

cm),

an

octadecylsilane derivatized s ilic a gel,
flow rate:

one m i l l i l i t e r per minute,

detection:

either the visib le at 450 nmor

the u ltra v io le t at

254 nm,
injection volume:

y 1 of a one to two mg/ml solution of the

10

anthracycline in mobile phase,
pressure:

about

temperature:

100

atmospheres,

ambient.
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A ll

chromatographic runs were done with the isocratic eluant

described.

The solvent

system was pretreated

by f ilt e r in g

it

through a 0.22 n - filte r and degassing i t under vacuum fo r 15 to 20
min.

Further degassing was done by slowly and continuously bubbling

helium gas through the solvent.
Reduction with Inorganic Reducing Agents
Aqueous S solutions, about 200uM. were buffered to various pH's
with eith er O .ljl I r i s or 0.1]1 phosphate buffers.

Then e ith e r solid

sodium borohydride (NaBH^, Ventron Corp; lo t number A- 8 ) or sodium
d ith io n ite (Na2 S2 0 4 , Fisher; lo t number 782959) were added to make
about 0.1% solution of the reducing agent.

The pH was rechecked and

readjusted i f necessary, then the uv-vis spectra of these solutions
were determined and compared.
were extracted
chloroform.

with

0.5

In addition the treated solutions

volume of eith er methylene chloride

or

These extracts were analyzed by t ic .
Microbiological Methods

The starting m aterial for the enzyme isolation was a batch of
c e lls of the soil organism, S. steffisburgensis (UC-5044).
quantities
Figure

of

these

16 outlines

cells
the

were produced

in

Large

submerged cultures;

process for a 2 5 0 -lite r fermentation and a

description follows.
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G lu co s e
P e p to n e
B re w ers Y ea st
Ca (N 0 3 ) 2 * 7 H20
Tap W ate r

T ry p to n e
Y east E x tra c t
C e re lo s e
R . 0 . W ater
L a rd O i l

Figure 16.

10 g /1
5 g /1
3 g /1
0 .5 g /1
3 00 ml

5
5
20
25 0
500

Seed
F e rm e n ta tio n

g /1
g /1
g /1
1
ml

S t e r i l i z e 0 1 2 1 *0 f o r 30 m in ,
2 8 *0
A g it a t e 0 200 rpm
200 1 /m in o f a i r

Culture process.

Culture
Pure cultures of this organism, maintained within the Upjohn
culture

co lle ction,

were available

for

this

investigation.

The

organisms were maintained on eith er s te r ile soil stored at 4^0 or
agar slant cultures of Elizabeth's medium.

The composition of this

medium is:
Sucrose (Amalgamated Co.)

20 g/1

Brewer's Yeast (N u tritio n al Biochemicals)

5 g/1

Sodium n itra te (Mallinckrodt)

2 g/1

Potassium dihydrogen phosphate (Fisher)

2 g/1

Magnesium phosphate (Mallinckrodt)

1 g/1

Tap water
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Seed Culture
Autoclaved,

medium-containing

shake

flasks

were

inoculated

eith er from a platinum loop transferred from the agar surface or
from a small soil sample.

The seed was then incubated f o r . 48 hours

on a continuous shaker at 280C.

The i n it i a l composition of the seed

medium was:
Glucose (Difco Laboratories In c .)

10 g/ 1

Peptone (Difco)

5 g/1

Brewer's yeast (N utritio nal Biochemicals)

3 g/1

Calcium n itra te heptahydrate (Fisher)

0.5 g/1

Tap water
Fermentation Culture
Although three sizes of fermentation culture were used, the
following medium was used for a ll:
Glucose (Cerelose, Clinton Corn)

20 g/1

Tryptone (Difco)

5 g/1

Yeast extract (Difco)

3 g/1

Lard o il - antifoam (Margot Treakner)

.

0.2%

Deionized water
Tw o-liter feniientors
Fermentation cultures of two lit e r s were run on the laboratory
bench

top

sintered

in

glass

8

-1,

stoppered,

sparger

for

the

erlenmeyer

flasks

introduction

of

f it te d

with

a

s te r ile - filt e r e d
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a ir .

Once seeded, the culture was agitated on a magnetic s tir r e r

for about 3 days.

No temperature control was used.

Tw enty-liter fermentors
The tanks of the 20-1 fermentors located in the fermentation
p ilo t plant of the Fermentation Research and Development unit at The
Upjohn Company were jacketed and agitated with a rotary im peller.
During the fermentation, a ir was added at 20 1/min.
rate was 400 rpm.

The agitation

The fermentation time was 5 clays.

Two hundred and f i f t y - l i t e r fermentors
The configuration of the 250-1 fermentation vessels was sim ilar
to the 20-1 fermentors described.
the a ir rate was

200

1 /min,

The fermentation time was 5 days,

and the agitator speed was

200

rpm.

Miscellaneous
Enzyme Storage
Solutions of purified enzyme concentrate were stored in aqueous
buffers between pH 5 and 9 at 4°C.
NADH Storage
Although freshly made NADH solutions (5mM) were used for most
studies,

NADH solutions

in

lOmM carbonate buffer

at pH 10 were

stored for several days at 4oc as suggested by Lowry, Passoneau, and
Rock (1961).
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Conductivity
Conductivity
Instruments

determinations

Incorporated

RC 16-8

were

made

with

conductivity

an

Industrial

bridge.

It

was

calibrated against 0.001N.KC1.
Screening
Not only cfe of other organisms but also several commercially
available reductases were screened for th e ir S-reductase a c tiv ity
using the standard

assay.

Some of the organisms screened were:

Streptomvces nogalater. elgretens. and spectabalis; Cor.vne simplex;
and Septomixia a f fin is .

Some of the enzymes tested were:

diaphorase (Sigma, lo t number 48C-6840 from Cl. kluyver i ) ;
xanthine oxidase - ECl.2 .3 .2 (Sigma, lo t number llF-3915 , from
butterm ilk);
dihydrofolate

reductase

-

ECl.5.1.3

(Sigma,

lo t

number 90F-

9540, from bovine liv e r ) ;
dihydropteridine reductase - ECl.6.99.7 (Sigma, lo t number 99C7000, from bovine liv e r ) .
F iltr a tio n
Protein solutions were both c la r ifie d and s te riliz e d by passing
them through Nalgene disposable membrane f il t e r s having eith er 0.45
or

0 .2 2

y sized pores.
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Active Band Location
Several
described
studies

standard disc

in

the

was

gels

were heavily

assay methods.

eith er

the

A ffig e l

f iltr a t io n eluate concentrate.

loaded and run as

The enzyme solution fo r
eluate

concentrate

or

these
a

gel

APter electrophoresis was completed,

one of the gels was divided transversely into 0.5-cm pieces.
piece was macerated in test tubes containing about

1

Each

ml of buffer.

A ll gel slurries were centrifuged at top speed for 15 minutes on an
International

C linical

Centrifuge

(Model SC-10).

The supernatant

from each gel section extract was assayed by both the standard and
the original
were

chromatographic assay.

stained

by

the

standard

The remaining

gel

columns

method.

Acrvlamide and BIS R ecrvstallization
The c ry s ta lliza tio n

methods described by Shuster (1971) were

used to purify both the 313 and the acrylamide before i t was used to
make gelling solutions.
solution

in

acetone

BIS was recrystallized from a saturated

and

acrylamide

was

recrystallized

from

a

saturated chloroform solution.
pH Measurement
Throughout the studies reported herein, the pH of the various
solutions and buffers was measured using a Beckman Expandomatic SS-2
pH meter

f itte d

with

a

Markeson

combination

pH electrode.
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Photography
A Polaroid MP-3 Land camera loaded with Polaroid black

and

white film (ASA 3000) was used to photograph both the t ic plates and
the stained gels.
Tic plates
The developed t ic
toward

a

plates

long-wavelength

uv

were placed with
lamp

the

(M ineralight,

s ilic a

side

UVSL-25)

and

photographed through a yellow f i l t e r ( V iv ita r , N8 , K2) at f-4 5 with
a

20

second

available

to

exposure.
the

film

Consequently,
was

that

from

the
the

only

vis ib le

fluorescence

lig h t
of

the

anthracycline-containing zones.
Gels
The stained gel columns were placed on a lig h t box (Heath) and
photographed through both yellow and red ( T i f f en 6-25) f il t e r s at f 45 and 1/4 second.
2,6-Dichlorophenol Indophenol Assay Conditions
Assays fo r the a c tiv ity of the enzyme on DCIP were performed at
600 and 340 nm in O.IJ^I phosphate at pH
was about 200 jjM.

8

.

The concentration of DCIP

A ll other assay conditions were sim ilar to those

reported for the standard assay.
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CHAPTER I I I

RESULTS

Enzjrme Assays
A ll of the techniques and conditions that were used to monitor
the enzymic reduction of Steffimycin (S) at the expense of NADH are
summarized in Table 9.

Some definitions and the techniques listed

w ill be reviewed, compared, and contrasted below.
Diaphoretic A c tiv ity
The

diaphoretic

a c tiv ity

is

the

a b ilit y

of

the

enzyme to

oxidize NADH without S or some other substrate being present in the
reaction mixture.

Under the conditions at which the standard assay

was normally performed, the diaphoretic a c tiv ity was about 30% of
the rate observed in the presence of S in even the purest enzyme
preparations.
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Table 9
Enzyme Assays

Instrument

Measured
Species and/or Rate

O2 electrode

^[2 2 -lsol
At

Spectrophotometer

A[NADH] (240 nm)
At

Hplc

ESR

KEY:

2 30 g

'

A[SH?] a [S]
At '
At *

23 0 ^ or
0

(-0 .8 9 V),

Polarograph

[ 0 2 ]sol%
RT and 25’ C

( -0 .5 ,- 0 .9 , &-1.0 V)

A[7-deoxyaqlycone]
At

A[SH-]

Q

0

?

t = time; A = change and.
[Oglsoi = the dissolved oxygen concentration,
[NADH] = the NADH concentration,
[S] = S concentration,
[SHg] = hydroquinone concentration,
[SH’ ] = semiquinone concentration,
[NAD"*"] = NAD'*’ concentration,
[7-deoxyaglycone] = 7-deoxysteffimycinone concentration.
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Specific Rate
At concentrations of both S and NADH that saturated the enzyme,
the S reduction rate increased as the to ta l amount of enzyme in the
assay solution
conditions
concentration.
assay.

increased;

seemed

to

however, the specific rate under these
decrease

with

increasing

enzyme

This is illu s tra te d in Figure 17 for the standard

The figure shows the effe ct on the specific rate not only of

increasing

the

enzyme

concentration

in

the

solution

but

of

increasing the S concentration also.

30

Increasing
enzyme
concentration

100

Figure 17.

Dependence of the specific rate on the enzyme and
steffimycin concentrations.
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Irrespective of the assay techniques used, the i n it i a l rate of
the enzyme reduction decreased with time.
18 and 19.

This is shown in Figures

Figure 18 shows the absorbance at 340 nm plotted against

the time when the measurement was taken, reflec tin g NADH
consumption.

lOiiM steffimycin
1 0 0 iiM NADH

t>

<x>0— o

Time [min]

Figure 18.

Absorbance at 340 nm during the course of the anaerobic
assay.
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Figure 19 emphasizes that the i n it i a l rate decreases.

I t shows

the time dependence of the logarithm of the ra tio between the NADH
concentration

at

a

given

time

and the i n it i a l NADH concentration.

0*75-

0-25

50

100

min

Time

Figure 19.

Logarithm of the i n it i a l ( i ) absorbance divided by the
absorbance at time t versus time for the anaerobic
assay.

Oxygen Electrode
Either an oxygen electrode or a spectrophotometer were used to
follow

the

reduction

reaction

continuously.

absorbance at 340 nm reflected a decrease in NADH.

The

change

of

With the oxygen
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electrode

neither

reduction

the

products

nor

were measured d ire c tly ,

oxygen from the solution.

reactants

of

the

enzymic

but one observed depletion of

In oxygenated solutions i t was possible

to detect neither a change in the concentration of S nor in the
concentration of SH2 and SH'.
the

reaction

resulted

mixture

being

In addition, injecting catalase into
monitored

by

the

oxygen

electrode

in a decrease in the rate of oxygen depletion from the

assay solution.

This is shown in Figure 20.

0.1 ml of lOmM S in
DMF

0.2 ml Enzyme

10 X Catalase
/

0 . 1%

200

W
160-

Time

at pH

6

, 167|iM NADH, at 28°C, and
0.94 atm

Figure 20.

Oxygen electrode studies.
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Polarograph1c Assay
By analogy with polarographic studies of anthracyclines
anthracycline

derivatives

polarographic

wave

electron,

at

by

-0.45

Rao
V for

et

a l.

(1978a

and

S was attributed

b ),

to

and
the

the 2-

2-proton reduction of the 5,12-quinone system, and the

other two peaks at -0.88 V and -1.1 V each to a one-electron, oneproton

reduction

processes

en

route

to

1 0 -dihydrosteffim ycin.

Equations of these electrochemical reductions are shown in Figure

21.

Steffimycin
Hydroquinone

Steffimycin
0 .4 5 V

DI IQ
4 0

OH

DIGIQ
H

O Steffose

OH

OH

O S teffose

1 0 - di

hydros te f f i mycin
hydroquinone

^ _ 2 hL
OH

Figure 21.

OH OH

^

0

.

%

O S te ffo s e

Proposed polarographic reductions of steffimycin on a
mercury electrode.
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The enzymic reduction was monitored using polarography.

The

anodic peak at -0.88 V (corresponding to the reduction potential of
NAD in this

system)

appears during the course of the reduction.

Furthermore the remaining observable steffim ycin reduction peaks at
-0.45 V and -1 .1 V decreased in height as the reduction occurred.
No new peaks appeared.
occurred with time.

Figure 22 demonstrates the changes that

Methylene chloride extracts of the solution in

the polarographic c e ll

a fte r 900 minutes (15 hours) showed no 7-

deoxysteffimycinone when analyzed by t ic .
Anaerobic Assay
When the

course

of

the

anaerobic

enzymic S reduction

was

followed by hplc using a c arefu lly degassed mobile phase, the S peak
decreased with time.

(The chromatographic peak height is a function

of the amount of m aterial in jec ted .)
formed, i t was undetectable.

I f 7-deoxysteffimycinone was

However, another peak, separable from

S, 10-dihydrosteffimycin, and 7-deoxysteffimycinone, appeared as the
reaction progressed.
that

of

addition,

The retention time of this peak was less than

10-dihydrosteffimycin,

7-deoxysteffimycinone,

or

S.

In

although the compound producing the peak had no 450 nm

absorbance lik e that of S, i t had a large 254 nm absorbance.

Figure

23 shows the peak height versus time for both S and the 254 nmabsorbing compound.

The shaded hexagons are the peak heights in mm

for S, the open circles represent one-tenth of the peak heights of
the new peak.
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S(5,12-quinone)

— - 50
—

^
900 mm

0.5 ml A ffig e l eluate
O.lmM POif b uffer pH 7.0
O.lmM in S
o . 2 mM in NADH
Ü = SmV/sec

Current
1

NADH
S(lO-Oxo)

Voltage

Figure 22.

The course o f the enzymic reduction by polarography.
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R e d u c tio n
p ro d u c t

^peak^heiqht^

Steffimycin

50

100

min

Tim e

F ig u r e 2 3 .

A n a e ro b ic r e d u c t io n p r o d u c t fo r m a t io n .
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ESR
With the conditions used, no free radical signal was detectable
by ESR.
about

1

The samples were rechecked a fte r having been incubated for
hour at room temperature; again no radicals were detected.

Precision - Accuracy
The
given

deviation from complete reprodu cibility when repeating a

enzyme

illu s tra te d

assay was shown to

be ±

6 %;

however,

the

effe ct

in Figure 17 resulted in unavoidable inaccuracies when

assaying solutions of varying enzyme concentration.
Enzyme P u rificatio n
The overall yield obtained from the cfe using the p u rificatio n
procedure designed was about 9%.
in Table 10.

A summary of the process is shown

The details of each of the steps listed follow .
Table 10

Enzyme P u rific a tio n
Sample

s.

Total
A c tiv ity
(EU)

S p ecific
Rate,
, Yield
(nmol-m in-l-mg-1) (%)

P u rific a tio n
(X)

s te ffis b e rq en s is

C ell fre e e x tra c t

6 .8

0.3

100

-

(NH4 ) 2S04 p re c ip ita tio n

6 .0

0 .6

88

2

OEAE elu ate

8 .8

2.4

130

8

G-150 elu ate

1.8

8.0

23

27

A ffig e l-B lu e elu ate

0 .6

350.0

9

1200
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Cellulose Ion Exchange Chromatography
The f ir s t

chromatographic

step

of

the

OEAE-ceilulose ion-exchange chromatography.
have a high capacity.

p u rific a tio n

was the

This sorbant seemed to

More than a l i t e r of enzyme-rich cfe could be

applied to the column before the spent or wash contained a c tiv ity .
The desorption p ro file is shown in Figure 24.

The solid circles

represent

eluate,

triangles

the

protein

concentration

of

the

assay, and the hexagons represent the conductance.
used,

the

open

represent the enzyme a c tiv ity detected by the standard

little

fractions.

a c tiv ity
The

was present

a c tiv ity

concentration of about 1^.

eluted

in

eith er

from

the

At the loadings

the

spent or wash

column

at

a

salt

The solid bar represents the portion of

the active eluate pooled and concentrated fo r the gel f ilt r a t io n
step.
Gel F iltr a tio n
Part of the gel f ilt r a t io n elution p ro file is shown in Figure
25.

The solid circles again represent the protein concentration and

the open hexagons represent the enzyme a c tiv ity .
volume was determined to be 400 ml.
portion of the eluate pooled.

The exclusion

The solid bar represents that

From this

step

in the isolation

sequence onward, the enzyme concentrate could be stored at 40C for
months with l i t t l e loss in enzymic a c tiv ity .
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Pool

o

i

§
s
I
5

Fraction (15 ml)

Figure 24.

DEAE-cellulose desorption.
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Pool

exclusion volume
(400 ml)

!
S

Fraction (~10 ml each)

Figure 25.

Gel f il t r a t i o n chromatography.

A ffi ni t v Chromatography
The a f fin ity
sepharose

m atrix.

support was a Cibachron blue dye attached to a
The

a f fin ity

of

NADH-

or

NADPH-requiring

dehydrogenases for these chromatographic supports is postulated to
be due in part to the s im ila rity in molecular structure between NADH
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and the dye (Stellwagen, 1977; Edwards and Woody, 1979).

Figure 26

shows the molecular structures of both NAD'*’ and Cibachron Blue.

Cibachron Blue
+

0

NFL

^

SQNd

SC^Ncj

/

^

N-^

H
NH'
NAD

'OH

O —P—

HO-

OH

■p

HO

Figure 26.

Structures of Cibachron Blue and NAD'*’ .

The a f fin ity
Figure

27.

column wash and elution

As before

the

solid

circles

p ro files
represent

concentration; the open hexagons the enzyme a c tiv ity .

are shown in
the protein
The diagonal

solid line is the salt gradient used to elute the a c tiv ity from the
column, and the horizontal bar indicates the eluate that was pooled.
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Pool

o

?

!

i

il

I

ë

I
<

Wash
Fractions

Figure 27.

Elution
Fractions (lu ml)

A ffigel Blue chromatography.
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Isolation Studies
Although development of the isolation process required numerous
isolation

studies,

only those that provided information not only

about the isolation process but also about the characteristics of
the enzyme are reported in the following section.
Preparative iso electric focusing
Although

the

preparative

iso electric

focusing

systems

used

seemingly performed w e ll, only an in sig nificant amount of enzymic
a c tiv ity

could

be

isoelectric focusing.

found

among

the

fractions

assayed

The enzyme was nevertheless active

afte r
in the

presence of the c arrier ampholytes and the G-75 gel, and i t remained
active for several weeks at 4°C in this environment.

Regardless of

th is , the is o e le c tric a lly fractionated cfe was inactive.
shows a typical

Figure 28

isoelectric focusing run of cfe starting m aterial.

Bars represent the 280 nm absorbance of each fra c tio n , the triangles
represent

the

absorbance

at

450

nm (a

function

of

the

fla v in

content) of each fra c tio n , and the diagonal curve represents the pH
gradient formed.
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Bargraph = Absorbance at 280 nm (AbSggg'
Û

= Absorbance at 450 nm (Abs.cn)

Abs^
‘450
0.08

3.06

0.6

0.04

Fraction

Figure 28.

Preparative is o e le c tric focusing.
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Buffer pH versus a c tiv ity extracted
Apparently the enzyme was Insoluble around pH 5,
inactivated a fte r having been precipitated at this pH.

and i t

is

Figure 29

shows the a c tiv ity detected in the supernatant when m illed c e lls
were treated

with

extraction

buffers

at various pHs.

The open

hexagons represent the enzyme a c tiv ity in the supernatant at each
pH.

In addition, when the cfe was extracted at pH

to pH 5, a precip itate formed.
of the i n it i a l a c tiv ity .
8

extraction

recovered.

b u ffer,

8

and readjusted

The supernatant contained only 10%

When the p recipitate was resuspended in pH
only

40%

of

the

in it i a l

a c tiv ity

was

This is less than h alf of that normally obtained by an

(NH4 ) 2 S0 4 precip itatio n .

Specific rate (nmoles*min'^*ml"^)

Figure 29.

A c tiv ity extracted versus pH.
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A ffin ity adsorbant screening
When a gel f il t r a t i o n eluate was loaded onto 1-ml mini-columns
f i l l e d with three types of sepharose-bound dye ligands, the Blue A
and Red A types adsorbed most of the a c tiv ity that was applied.
Figure 30 shows the structure of the dye ligands used.

O ÏX Î
"

1 (Cibachron
Blue)

SC^Na

Pôr-iJ'
'

Red A
(Procion Red)

Blue B
(Copper phthalocyanine)

Figure 30.

Dye ligands:
1980).

Possible p a rtia l structures (Fulton,
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Table 11 gives the enzyme a c tiv itie s in the spents, washes, and
eluates from each.

Both Red A and Blue A eluates contained more

a c tiv ity than that in the Blue B eluate, and, although the Red A
appears to have adsorbed more a c tiv ity than the Blue B, the flow
rate of the Red A mi n i-column was less than o n e -fifth that of eith er
the Blue A or B columns so the results are not d ire c tly comparable.
Table 11
Dye Binding Studies

% of Starting Material A c tiv ity

Adsorbent

Spent

Wash

Eluate

Gel matrix (Control)

. 94

32

13

Red A

12

6

100

Blue A

22

8

87

Blue B

58

33

57

A ffin itv chromatography of the cfe
The a c tiv ity

in the cfe was retarded s lig h tly as compared to

the bulk of the protein in solution as i t passed through an A ffig e l
Blue column, but l i t t l e

a c tiv ity was adsorbed.

The elution p ro file

of the protein concentrations and enzyme a c tiv itie s
feed

and wash fractions

are

in

Figure

31.

in the spent

The solid

circles
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represent the protein concentration and the open hexagons the enzyme
a c tiv ity .

The spent and wash contained about 75% of the to ta l

loaded a c tiv ity .

There was minimal p u rific a tio n .

A ffin ity chromatography—elution with NAD'*'
There

was l i t t l e

indicating

a c tiv ity

in

the

spent

or

wash fractions

that the a c tiv ity was adsorbed by the A ffig e l Blue, but

at the conditions and concentrations used, the amount of a c tiv ity
eluted

from

an enzyme-loaded

A ffig e l

Blue

column

by

the

NAD'*'

solution was in s ig n ific a n t.
Enzyme Characterization
The p urified enzyme is a soluble enzyme, acidic, and a single
polypeptide chain.

Throughout the remainder of this dissertation

the term enzyme w ill refer to this NADH dependent reductase.
12

Table

summarizes additional properties of the enzyme, and what follows

w ill

be

the

details

of

the

results

obtained

during

the

determinations of these properties.
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i

s
ë

Spent

Wash
Fraction (10 ml)

Figure 31.

A ffig e l chromatography on a c f e .
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Table 12
Enzyme Properties

Molecular mass

80K daltons

Iso electric pH (p i)

5.5

Coenzyme

NADH

Apparent

for steffimycin

10 - 19p]1

Apparent K|v| fo r NADH

65;^

Subunits

0

Prosthetic groups

0

P articulate

No

Active temperature range

4 - 40^0

Active pH range

4.5 - 9.5

pH Optimum
The purified enzyme has a sharp pH optimum between 5 and 5.5.
This is shown in Figure 32 as determined using the standard assay.
A

sim ilar

curve

and

optimum

were

obtained

using

the

oxygen

electrode.
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ço Q
I

pH

Figure 32.

Effect of pH on the enzyme a c tiv ity .

Molecular Weight and Subunits
The molecular mass as determined by SDS-gel electrophoresis was
75 to 85 K daltons.

One band was detected using this technique.
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Ill
Based on the volume of buffer needed to elute the enzyme from a
calibrated gel f ilt r a t io n
to be 70 to 90 K daltons.
for the molecular mass,

column, the molecular mass was estimated
Since both techniques give sim ilar values
it

was concluded that the enzyme had no

subunits.
Is o e le c tric pH
Based
analytical

on

both

the

iso electric

p recipitation

studies

described

and on

focusing, the isoelectric pH of the enzyme

seemed to be about 5.5.
Prosthetic Groups
Determining

the presence or

absence of

a prosthetic

fla v in

moiety associated with the p urified enzyme was approached from two
directions:

the f i r s t

involved measuring the uv-visib le spectrum -

■and the fluorescence of the A ffig e l eluate concentrate; the second
used

fla v in

enzyme.

suicide

substrates

in

an attempt

to

inactivate

the

Figure 33 shows the uv-vis spectrum of the A ffig e l eluate

concentrate
s e n s itiv ity .

and

the

same spectrum at

ten

times

the

instrument

The broken lin e is the type of spectrum expected for a

flavo-enzyme such as xanthine oxidase.

The isolated reductase did

not have an absorbance spectrum sim ilar to known flav o - or ironsulfur enzymes.

In addition,

the enzyme showed no fluorescence

characteristic of a fla v in , and f in a lly , i t was not inactivated by
fla v in suicide substrates at the conditions used.
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expected
spectrum
with
flav in
prosthetic
group \

,1 0 x

■e

Wavelength

Figure 33.

Enzyme spectra.
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Kinetics
Within the constraints imposed by the inaccuracies inherent in
the

i n it i a l

rate

measurements,

the

apparent

Michaelis-Menten

constant (K|v|) and maximum velocity (V^ax) for both S and NADH were
determined.

In the case of S both K|^ and

the

concentration

enzyme

in

illu s tra te s this dependence.
G-150 eluate.

the

assay

seemed to depend on
solutions.

Table

13

These kinetic studies were done on a

The ranges of K,^ and V^gy for NADH were about 60yM

and 35 to 80 nmoles*min"l*ml"^ respectively.
Table 13
Variation in K|v| and V^^x of Steffimycin
with Enzyme Concentration

Km

Vmax

Volume of
Enzyme used

{^ë)

(nmol'min^lml-1)

(x)

10

43

12.5

14

34

50

15

29

100

18

27

200

Cofactor Requirements
The coenzyme NADPH was not oxidized

in the presence of the

p u rified enzyme and steffimycin at the conditions tested.
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Substrates
The following compounds were tested fo r the a b ilit y to increase
the

NADH oxidation

standard assay.

rate

in

the

presence of

the

enzyme in

the

Table 14 gives the rate with each of these as

substrate re la tiv e to the rate with S as substrate at pH
exception of DCIP).

6

(with the

The structures of a ll the compounds tested are

shown in Appendix D.
Table 14
A c tiv ity of Substrates
Relative to that of Steffimycin

Class

Compound

Relative Rate
%

Anthracyclines

7-OMEN
Nogalamycin
Steffimycin B
7-deoxysteffimycinone
Steffimycin C
Steffimycin
Adriamycin
Daunomycin

Dyes

Methylene Blue
2,6-Dichlorophenol indophenol (pH
Purpurin
A liza rin

Other

Menadione
Riboflavin
Shikimic acid
Quinic acid
Oxalacetate diethyl ester

15
20
20
60
100
100
0
0

8

)

80
50
0
0
170
30
0
0
0
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Anthracyc11nés

.

By the method indicated, the order of increasing oxidation rate
was:

7-OMEN < nogalamycin = steffim ycin B < 7-deoxysteffimycinone <

steffim ycin C - S.

Neither adriamycin nor daunomycin under these

conditions seemed to affe ct the rate of NADH oxidation.
Dyes

Neither of the two hydroxylated anthraquinones tested served as
enzyme substrates; that is , they did not a ffe c t the rate of NADH
oxidation.

Both DCIP and methylene blue, however, seemed to serve

as enzyme substrates.

Reactive Blue 2 (Cibachron Blue) inhibited

the enzyme.
Others
The only compounds among those tested that were substrates for
the

enzyme

produced

an

were

rib oflavin

NADH oxidation

and menadione.
rate

higher

Although

than

menadione

S under

sim ilar

conditions, i t also effected a rapid non-enzymic oxidation of NADH.
In hibitors and Inactivators
Under conditions where the enzyme appears to be the most active
with S as the substrate, the following compounds seemed to in h ib it
the

reduction:

daunomycin,

p(hydroxymercuri)benzoic acid.

Cibachron

Blue,

w arfarin,

and

The enzyme was inactivated in the

presence of both Triton X-100 and SDS.
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Appendix

E shows the

structures

of mostof

the

compounds

mentioned in this section.
Preincubation Studies
Preincubation of the enzyme with S has a minimal effe ct on the
i n it i a l NADH oxidation ra te .
Dissolved Oxygen Effect
The

rate

of

the

enzymic

reduction as

determined by

the

spectrophotometric assay seemed to depend on the amount of oxygen in
the assay solution.
least

rapid

in

The rate was greatest in anaerobic systems and

solutions

saturated with pure oxygen.

shows a comparison of the absorbances
reaction

mixtures

represented

measured

by open

circles

triangles was anaerobic.

at

the

was

at 340

times indicated.

aerobic and

Figure 34

nm of two sim ilar

the

one

The

one

by

open

The amount of divergence between the two

obviously increases with time.
U1 tra cen tr 1 fugat 1 on
A fter ultracentrifugation of both cfe and DEAE eluates at about
100 K times g ravity, the enzyme was found only in the supernatant.
The precipitates obtained were inactive.
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O.IN PC., pH 6.0
lOiiM steffim ycin
lOOiiM NADH
lOx A ffigel eluate

%
O
o
enzyme
added

Q>
ZV
A

Q)
CD

0.5

CD
Aerobic

AA

Anaerobic
6-

Figure 34.

40

80

120

160

200 min

Comparison of anaerobic and aerobic assays.
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steffim ycin and Steffimycin Derivatives
Steffimycin was the substrate used most frequently.
th is , S was subjected to some analytical scrutiny.

Because of

The re s u lt was

that some new, unpublished information about S was obtained.
section summarizes some of that information.

This

The uv-vis spectra of

S in aqueous buffers at several pHs are included in Appendix F.

It

is obvious from these spectra that S is a pH indicator that changes
from yellow in acid to red -vio let in basic solutions.
S o lu b ilitie s
The s o lu b ility of S in aqueous buffers at RT was 0.27 mg/ml or
about 0 .4 7 uM; the s o lu b ility of 7-deoxysteffimycinone was almost an
order of magnitude lower than that of S.
Fluorescence
Figure 35 shows both the emission and excitation spectra of a
0.7mM S solution in methylene chloride.
at

320

(minor)

and 373

nm.

The excitation maxima were

When excited

at

eith e r

of

wavelengths, the emission maxima were 575 (minor) and 515 nm.

these
The

color of the fluorescence is yellow-brown.
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A.

“ 2 )0

Excitation spectrum

3ÏÔ

3^

Excitation ho.

B.

Emission spectra
•370 nm excitation
320 nm excitation

0

0,

0

500

600 nm
Emission hu

Figure 35.

Fluorescence of steffim ycin.
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Although S is almost too weak an acid to be titr a te d in aqueous
solutions, from the titr a tio n curve shown in Figure 36 and from the
absorbance changes observed as the pH is varied, the apparent pKg of
S in aqueous solutions at RT appears to be about 7.5.

p K = 7.5

equivalence point

ViEqui va lents OH" Added

fig u re 36.

Aqueous S titra te d with sodium hydroxide.
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Reducing Agents
The effects observed when aqueous S solutions were treated with
reducing agents were dependent upon the reducing agent used and to
some extent on the pH of the reaction mixture.
Sodium dith io n ite reduction
Figure 37 shows the effects observed when an aqueous S solution
(pHo,7.5) is treated with Na2 $ 2 0 4 ('vO.1%).
also shown in th is fig u re .

The reoxidation of S is

As reoxidation occurred, the spectrum of

the reduction product reverted to that of the starting m aterial.
one maintained anaerobic conditions fo r about

20

If

min, extracted the

reduced mixture with methylene chloride, and analyzed each extract
by t i c ,

one obtained an approximately 30% conversion of S to 7-

deoxysteffimyci none.
Sodium borohydride reduction
In

contrast.

Figure

38

shows the

effects

on the

spectrum

obtained by treating aqueous S solutions with NaBH^ at the indicated
pHs.

Furthermore, the spectrum did not change sig n ific a n tly afte r

the solutions equilibrated with a ir fo r about 12 hours.
each

solution

Extracts of

contained no appreciable concentration of 7-deoxy

steffimycinone.
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700

500

3Ô0nm

Wavelength

Figure 37.

Effect of steffimycin reduction v/ith sodium d ith io n ite
and reoxidation with a ir on the v is ib le spectrum.
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O.IN PO^
lOOptl steffim ycin
mg/ml NaBH.

600

400

200

nm

Wavelength

Figure 38.

Effect of steffimycin reduction with sodium borohydride
at various pH's on the v isib le spectrum.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

124
Polaroqraphy
Standard dc polarography of
complicated reduction wave.

aqueous S solutions produced a

The results of scans from 0 to -1 .5 V

at a one-second drop-time for 20uM S in both O .lji phosphate buffer
at pH

6

and buffer containing 50uM NADH are in Figure 39.

The

reduction potential fo r S in buffer at RT seemed to be about -0.45
V.

Figure

40

shows a comparison of several

d iffe re n tia l

pulse

polarograms of daunomycin and S produced under sim ilar conditions.
D iffe re n tia l pulse polarograms run on S solutions at pH's between pH
6

and

8

showed a pH dependence of the reduction potential at -0.5V

to be about 58 mV per pH u n it.
ÜBlç
The retention times of 10-dihydrosteffimycin, S, and 7-deoxy
steffimycinone

were 4 .1 ,

4 .8 ,

and 11.3 min respectively

in

system used (a c e to n itrile ; water; THF-45:50:5 on C^g s ilic a ) .

the
The

chromatograms of the compounds above, monitored at 254 nm, are shown
in Figure 41.

Figure 42 shows the chromatograms of mixtures of 10-

dihydrosteffimycin

and S with

reaction at 120 min.

a sample drawn from the anaerobic

The peak at 3.5 min, which appears during the

course of the anaerobic enzyme reaction, has no 450 nm absorbance.
Had 7-deoxysteffimycinone been produced as the anaerobic reaction
progressed, i t should have been eluted in the position indicated by
the arrows in Figure 42.
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E lectrolyte: O.IN PO^, pH

6

Curve A: lOpM steffimycin
Curve B: lOpM S and 50p[j NADH

0 - t j.L : 1

Figure 39.

I !'i ll.'li

Standard dc polarography of aqueous steffim ycin.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

126
Electrolyte: O.IN PO^, pH

6

Curve A: lOuM steffimycin and
50pM NADH

Curve B: lOpM S

D
Curve C: lOpM daunomycin and
50 M NADH y

Curve D: lOpM daunomycin

Background
-0.5

-1 .0
Voltage

Figure 40.

D iffe re n tia l pulse polarography of aqueous anthracycline
solutions.
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FIow rate: 1 ml/min
Solvent: Methanol, water
THF (50:45:5)
Pressure: '\60 atmospheres
Column: Whatman ODS-10
25 cm

7-deoxysteffimycinone

254 nm

Figure 41.

Steffimycin

254 nm

-di hydros te f f f myc i n

10

254 nm

Analytical hplc of steffim ycin and some steffimycin
derivatives.

254 nm

450 nni

1.0 AUFS

0.1 AUFS

V

w ,.„

AUFS = Absorbance Units Full Scale
Figure 42.

Anaerobic enzymic reduction of '^400 min plus added S
and 1 0 -dihydrosteffimycin standards.
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Microbiological
Fermentation
Instead

of

using

hydrophila

as

the

enzyme

source

as

McCarville (1977) did, th is investigator used S. steffisburqensis.
Since this organism grew fa s te r than A. hydrophila. i t was possible
to obtain higher c e ll weights per l i t e r of fermentation per day than
that

obtainable

from

hydrophila.

No medium improvement was

necessary; however, noticeably lush growth in shake flasks seemed to
occur at liq u id -a ir interfaces.

From this i t was concluded that an

adequate a ir supply might be important fo r improved c e ll yield s.
fa c t,

increasing

increased

the

c e ll

the

aeration

y ie ld

per

rate
lite r

in

fermentations

not

In
only

of fermentation per day but

inhibited the melanin production in the fermentation also.

Cells

from fermentations with a low a ir input had been black at harvest.
In current fermentations the cells are cream-colored.

The results

from both 20- and 250-1 fermentation tanks are in Table 15.
cells were harvested 4 to
a c tiv ity

in

6

days a fte r inoculation.

freshly collected cells

The

The

enzyme

was about 3 ^moles of NADH

turnover per min per gm of cells higher in the presence of S than in
its absence.
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Table 15
Fermentation Data

Volume

250 L ite rs

20 L ite rs

Seed to harvest

152

100

Harvest pH

5.1

5.8

hr

Cell yield - wet
- dry

2 0 gram s/liter
3.6 gram s/liter

70 gram s/liter

Enzyme a c tiv ity

3

EU per gram (wet c e lls )

A c tiv ity in Other Microorganisms
Nearly equivalent enzyme a c tiv ity
was

found

in

a ll

spectabalis. which had l i t t l e
had l i t t l e

on aper c e ll weight basis

Streptomyces tested with
a c tiv ity .

the exception of S.

A fungus, S. a f fin is , also

a c tiv ity , but aqueous extracts of dried C. simplex cells

seemed to be extremely active.
Dve Band-Activitv Correspondence
The

electrophoretic

m obility

of

standard PAGE gels to which an A ffig e l
46% of the gel length.

the

dye

band

present

in

eluate had been applied was

This corresponded to the location of the

enzyme a c tiv ity in transversely divided gels run on the same eluate
under sim ilar conditions.

The enzyme a c tiv ity was located using the

standard assay.
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CHAPTER IV

DISCUSSION

The work reported in this dissertation was directed naturally
toward

three

obviously
enzyme.

fo c i.

central

The f ir s t
to

the

was enzyme assays.

characterization

and

The second focus was on steffim ycin (S ).

was on the

isolation

Assays were

isolation

of

the

The last focus

and characterization of the enzyme from S.

steffisburqensis responsible for the reduction of S.
The

fir s t

part

of

the

discussion

section

w ill

be divided

according to these three areas.

Following that w ill be the current

understanding

mechanism

of

the

enzyme

as

deduced

from

the

characteristics of the enzyme, the properties and redox behavior of
S,

and the

information

gleaned from the

assay studies.

A few

suggestions for further investigations needed w ill follow th at.
Enzyme Assays
Comparison of the Oxidation and Reduction Rates by Various Assay
Techniques
:
An enzyme solution assayed by d iffe re n t techniques but sim ilar
conditions

of

pH,

temperature,

and

S and

NADH concentrations

produced eith er S reduction or NADH oxidation rates that seemed to
be related to one another in the following way:

the rate of NADH

130
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consumption in aerobic solutions was less than or equal to the rate
under anaerobic conditions; the anaerobic consumption rate of NADH
was

sim ilar

to

both

the

formation

rate

of

reduced

S and the

decreasing oxygen concentration in the assay solution; f in a lly , the
rate o f 7-deoxysteffimycinone formation at the pH optimum for the
p urified enzyme seemed to be orders of magnitude slower than the S
reduction

rate

as

measured

by

a ll

other

techniques.

The

relationship among them can be represented as:
AfNADHl

A[SH2 ]

At

At

^ A [ NADH]
^

A t

^ A
2

[O2 J

^ Af 7 - d e o x y s t e f f imvci none

At

1

At

Sources of Ambiguity in the Spectrophotometric Assays
The precision of the spectrophotometric assays used was quite
acceptable for a biological m aterials, but the inaccuracy between
one

enzyme

d ilu tion

and

another

caused

d iff ic u ltie s .

Several

attempts to explain these inaccuracies follow .
F ir s t,

the

apparent

inverse relationship

between the enzyme

concentration and the specific rate might have been, in part,
a r tifa c t of the method used to measure the i n it i a l ra te .

an

I t was

consistently taken to be the change in absorbance with time over the
f i r s t 5 min of the reduction.

Since the i n i t i a l rates appeared to

decrease with time, perhaps that method of measurement generated the
inverse relationships described.

For example, the i n it i a l rates of

a highly active enzyme preparation would tend to be underestimated
i f assumed constant for as much as 5 min, because such preparations
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might also be expected to produce more rapid deceleration.
Second, significant non-productive and non-effective binding of
S onto the enzyme might have occurred.
might bind s u ffic ie n t
solution.

High enzyme concentrations

S to e ffe c tiv e ly remove i t

Steffimycin

has

some

rather

from the assay

interesting

binding

properties that w ill be discussed la te r.
F in a lly ,
inconstant

there

i n it i a l

are

several

ra te .

possible

explanations

One probable explanation

products of the reaction inhibited the enzyme.

is

for

an

that

the

Another is that the

absorbance of the enzymic reduction product(s) was much greater than
that of S.
the

This, however, seemed unlikely for two reasons.

reduction

second,

the

products
i n it i a l

of

rate

S reacted
was

with

inconstant

F ir s t,

oxygen as shown,

and

in

and

both

aerobic

anaerobic assay solutions.
ESR
The

following

coproportionation

-

disproportionation

equilibrium has been emphasized previously:
s

+

SHg

2SH' ;

Since this equilibrium exists

Kgq

in aqueous anthracycline solu

tions, the production of eith er reduced species, semiquinone (SH’ )
or anthrahydroquinone (SHg) generates a f in it e concentration of the
other.

ESR

detects

only

the

semiquinones.

Apparently

the
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concentration
solutions.

of

semiquinone

Two possible

was

undetectably

explanations

for

low

this

in

are;

assay

that

the

semiquinone was extremely short-lived in the assay solutions and/or
that

the equilibrium constant,

tra tio n

was so low that the concen

of semiquinone in enzymically reduced aqueous S solutions

was below the level detectable by the spectrometer used.
Polaroqraphy
In th e ir study on adriamycin, Rao et a l.

(1978a) established

that the peak in cyclic voltammetry occurring at -0 .6 V corresponded
to

the

two electron-two

proton

reduction

of

the

5,

12-quinone.

Also, at 2Q0 the pH dependence of the reduction potential fo r a two
electron-two proton reduction is about 57 mV/pH unit (Molinier-Jumel
et a l.

[1978], Rao et a l.

reduction

peak

at

-0.5

[1978a]).

The pH dependence of the S

V was 58 mV/pH u n it.

It

was therefore

assumed that the process at -0.5 V corresponded to the 2-electron,
2-proton reduction of the 5 ,12-quinone of S and that the processes
at -0 .8 V and -1 .0 V corresponded to the 10-carbonyl reductions.
The polarograms made during the enzymic reduction
that

the concentration

of the

reducible

indicated

quinone species

solution decreased as the reaction proceeded.

It

in

the

is evident that

the reduction peak attributed to one of the reduction processes at
the

1 0 -carbonyl

Enzymic

group decreased as w e ll, although less dram atically.

reduction

of

the

chromophore,

i.e .

addition

of
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electrons into the ring system, produced a new compound with unique
reduction p o tentials.

This new compound was undetectable eith er in

the range observed or in the polarographic system,used.
of

7-deoxysteffimycinone

in

methylene

chloride

The absence

extracts

of

the

solutions in the polarographic c e ll seemed to indicate that the end
product of the chromophore reduction under these conditions was not
the elim ination product, 7-deoxysteffimycinone.
Oxygen Measurements
I t was assumed that the amount of reduced S which autoxidized
was

equivalent

preparations
accuracies
determine

to

were
of

the

the
used.

the

oxygen

standard

precise

and the

molar

oxygen and NADH consumed.

consumed

However,

it

when

p u rified

was d if f ic u lt
oxygen electrode

relationship

between

enzyme

within
assays

the

the
to

amount of

Since the oxygen consumption decreased

when catalase was added to the oxygen electrode assay solution, the
following sequence was assumed to be the probable reaction series
occurring within the electro lyte:

H+ +

S +
SH2

NADH
+

O2

2H2O2

SH2
Nonenzymatifi

-----------------------------

+

^

5

+

►

2H2O

NAD+

H2 O2

+

O2
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Anaerobic Chromatographic Assay
The anaerobic chromatographic assay described by McCarville et
a l.

(1977) was used extensively during the i n it i a l

research work reported here.

phases of the

I t became apparent, however, that i t

required significant modification in order for i t to be useful for
pure

enzyme

preparations

and

fo r

determining

parameters of the enzymic reduction.

some mechanistic

The impetus and direction for

these modifications are described below.
It

was

extracts (by

demonstrated both polarographically and

by analyzing

hplc) of an anaerobic standard assay that the formation

of 7-deoxysteffimycinone was not simultaneous with the disappearance
of NADH from the assay solutions.

It

was u nlikely that the 7-

deoxysteffimycinone was present but unobserved since the compound
had a large

fluorescence and partitioned qu a n titatively

into the

extractant.
Also the concentration of S used for the published assay was
shown to be in 3 to 5 fold excess of its aqueous s o lu b ility .

This

resulted in assay solutions that were unstable; S crystallized or
precipitated
assay.

out of some samples during the course

This

preparations.

occurred
It

was

less

frequently

demonstrated

that

with
S

cellu losic and proteinaceous m aterial and DNA.
in crude microbial extracts.

can

of the 3 hr
crude
complex

enzyme
with

These are abundant

Perhaps s u ffic ie n t S was bound to keep

the free S concentration below its saturation point.
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The extraction of the anaerobic chromatographic assay solutions
with

methylene

chloride

or

chloroform

uncertainties into the resu lts.
used

seemed

solvents

are

to

exacerbate

seemed

to

introduce

Some properties of the extractants

these

uncertainties:

notorious fo r fre e-rad ica l

reactions

fir s t ,

these

(Mason,

1979).

Second, methylene chloride is a good solvent for oxygen.

Therefore,

the extraction seemed to jeopardize the observation of any reactive,
reduced intermediates possibly produced during the enzyme process.
The p artitioning

of

S and

its

derivatives

into

eith er

the

chloroform or methylene chloride extractant varied with both the pH
and protein concentration in the samples.
quantitation.
quantitation

Also,

the analytical

of material

in

t ic

This tended to complicate

tools necessary for accurate

zones were unavailable

to

this

investigator.
F in a lly ,

trying

to

insure

anaerobic conditions

for

a large

number of 1-ml samples maintained at about 12° C above RT for 3
hours was cumbersome at best.
Steffimycin
Although a ll anthracyclines are complicated molecules, several
features

of

S made

anthracyclines.

it

This

somewhat more complicated
compound

around the saturated A-ring:
groups.

has

anomalous

than

functional

standard
groups

the 10-oxo, 9-methyl, and 7-methoxy

I t also has a 2-methoxy group and a sugar without an amine
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function.
7th

and

Furthermore, the absolute configuration around both the
9th

configurations

carbons

has

remained

may

be

d iffe re n t

anthracyclines.

undetermined.
from

that

One or
of

both

common

(Due to these anomalies Arcamone, Note 1, might

argue that S should be excluded from the anthracycline class of
a n tib io tic s .)
Properties of Steffimycin and Its Derivatives
What

follows

w ill

include

general

impressions

and

a

few

properties somewhat unsystematically and nonquantitatively observed
during the course of these investigations.
The p o la rity

of

S derivatives

deoxysteffimycinone, steffimycinone,

increased

in the order:

7-

steffim ycin C, steffim ycin B,

S, and 10-dihydrosteffimyci n.
The height of the f i r s t d .c. polarographic wave on a dropping
mercury electrode increased l i t t l e

upon addition of eith er NAD or

NADH to the electro lyte; however, there was a dramatic increase in
peak height upon the addition of NADH and NAD to the electro lyte
when

the

reduction

process

at

d iffe re n tia l pulse polarography.

about

-0 .5

V was monitored

by

Apparently inconsistent behavior

of this type was indicative of the adsorption of S onto the surface
of the mercury electrode

(Plambeck, Note 5 ) .

Steffimycin and it s derivatives were also strongly and, in some
cases,

irrev ersib ly adsorbed by, DEAE-cellulose, cellulose-acetate
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f i l t e r discs, and activated s ilic a .
In addition S and its
produced
Neither

dramatic

color

adriamycin

nor

derivatives were indicators that

changes

upon changing the

daunomycin

showed

this

solution

magnitude

of

a ll
pH.
pH

e ffe c t.
Inorganic Steffimycin Reductions
The exact molecular structures of the products obtained when S
was reduced

in

aqueous solutions

remain undetermined.

If,

with

inorganic reducing agents

however, chemical analogies are valid in

this case, a few reasonable structures for these reduction products
may be deduced from the published

inorganic reductions of other

anthracyclines whose product structures were determined.
Borohydride Reductions
Borohydride has a postulated reduction mechanism that involves
transfer

of a hydride

ion to the oxidant or essentially a two-

electron transfer (Walsh, 1979).

I t has been shown to reduce the

anthracycline

chromophore,

hydroquinone.

This decolorized the chromophore.

13-carbohyl
isomers.

group

was

converting

reduced

to

the

two

5 ,12-quinone

possible

to

the

In addition, the
anthracyclinol

Sim ilar products seemed to form as S was reduced with

borohydride.

The compound was bleached and hplc analysis showed a

number of peaks.

Figure 43 shows an isomer of one probable product

of the borohydride reduction of S.
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HO

HO

HO HO HO

O

-O "

H O - ^ OH '
0

Figure 43.

_

Postulated structure of borohydride-reduced steffim ycin.

These reduction products were stable to a ir reoxidation and to
the elim ination

of

steffose

to form 7-deoxysteffimycinone.

The

observed absence of an elimination reaction and the s t a b ility of the
two-electron

reduced S was supported by the cyclic

studies of Feinberg (Note 2) as w ell.

voltammetric

In his work the reduction

peak corresponding to the 2-electron, 2-proton reduction of the 7deoxysteffimycinone 5 ,12-quinone fa ile d to appear, and the processes
observed at high scan rate (u ) were also observed at low u , which
implies that the reduction product was r e la tiv e ly stable.
D lthio nite Reductions
In contrast, d ith io n ite was known to reduce oxidants via a free
radical

or

one

electron-type

mechanism.

In

the

presence

of
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d lth io n ite

anthracyclines

semiquinones

which

rap id ly ,

rearranged e le c tro n ic a lly ,
respective

were

reduced

to

spontaneously,

th e ir
and

corresponding
q u a n titatively

to elim inate the sugar and form th e ir

7-deoxyanthracyc1inones.

This reducing agent did not

seem to reduce the 13-carbonyl group.

Sim ilar behavior was observed

upon reduction of S with d ith io n ite .

The product had a spectrum

sim ilar

published

in

some

indigosulfonate,
radiolysis

respects
and

(Meisel,

to

those

daunomycin

semiquinones

1975 and Svingen, 1981).

colored product rapidly reoxidized to S in a ir .
electronic

rearrangement

to

fo r

duroquinone,

generated

by pulse

The unstable, wineI t was capable of

elim inate

steffose;

however,

the

note

c a ta ly tic

hydrogenation

elim ination was nonquantitative.
It

was

(reduction

interesting

via

to

a one-electron

that

mechanism)

deoxysteffimycinone (K e lly , et a l. 1977).

of S also produced 7The following reactions

are postulated fo r the reduction of S by dith ino nite and its a ir
reoxidation at neutral pH:
steffim ycin +

5 2 0 /^^"

+ ZHgO-» 250^" +

3 H^

+ steffim ycin semiquinone

steffim ycin semiquinone + Og—♦steffim ycin + HO2
The species represented have not been id e n tifie d but are postulated,
based on analogous d ith io n ite reductions.
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Comparison
Themechanism of

S reduction

and the

number of

transferred during the reduction with d ith io n ite
from that with borohydride.

electrons

appear d iffe re n t

I f the differences observed were simply

caused by the type of reduction undergone by the S chromophore, i .e .
one-electron reduction with d ith io n ite versus two-electron reduction
with borohydride,

then i t would appear that

the reductive cleavage

reaction proceeds much more readily for the S semiquinone than for
the hydroquinone.

I t is unclear why this should be so.

Also there

was a vast difference in the uv-vis spectrum between the two types
of inorganically reduced S.
Enzymically Reduced Steffimycin
The molecular structure of the end product produced during S
reduction by the reductase isolated from S. steffisburqensis remains
undetermined.

Several of its properties, however, could be inferred

from its elution time in the hplc system used, its behavior in the
oxygen electrode

studies,

presenceof a single,

and its

uv absorbance.

sharp peak eluting

Based on the

before both S and 10-

dihydrosteffimycin in the reverse phase eluent, the compound seems
to

be

a

compounds.
peroxide

single

species

and more polar

than

eith er

of

these

I t seemed to react rapidly with oxygen to form hydrogen
and had

no

absorbance

at

450 nm.

Nevertheless,

the

reduction product had a 254 nm absorbance about 5 to 10 fold higher
than that of S.

Some of these properties are sim ilar to those
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observed for hydroxylated anthrahydroquinones.
Absence of in vivo A c tiv ity
This investigation into the properties of S has shown i t to be
capable of redox cycling and other studies already cited have shown
i t capable of DNA binding in v itro (Bergy and Reusser, 1967).
data seem to f i t

These

some of the c r ite r ia necessary fo r antineoplastic

a c tiv ity as outlined in Table 4; nevertheless, S has minimal in vivo
antineoplastic a c tiv ity and low to x ic ity .
Structural s im ila ritie s between S and other anthracyclines were
helpful to understanding the chemical and enzymic reduction products
formed; however, i t w ill
structure

and

anthracyclines

be necessary to emphasize differences in

r e a c tiv ity
in order

th e ir biological actions.
these

differences

with

between

S

and

the

therapeutic

to understand the dramatic difference

in

What follows w ill be an examination of

respect

to

th e ir

possible

effe c t

on DNA

binding, bioalkylation, and autoxidation.
DNA Binding
The in v itro association constant between S and DNA is unknown,
but several structural features of S could prevent i t from binding
DNA as e ffe c tiv e ly

as daunomycin does.

X-ray

crystallographic

studies show the daunomycin chromophore intercalating between every
4.5 nucleotides.

The puckered A-ring and amino sugar neatly f i l l

the narrow groove in double helical DNA.

The amine functional group
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on the sugar of daunomycin is demonstrably important to th is type of
binding and S has no amine on its glycoside.

The configuration of

the groups around the A-ring of S may prevent i t from f i l l i n g the
narrow groove in double h elical DNA.

Reportedly (Arcamone, Note 1)

adriamycin which has the ^-configuration rather than the usual ^ configuration around carbon 9 was completely inactive.
general

structure

daunosamine.

of

steffose

is

vastly

d iffe re n t

Also, the

from that

of

This could have a pronounced effe ct on DNA binding.

F in a lly , the ir-electrons of the carbonyl group at the 10th carbon of
S can probably be e lectro n ic ally conjugated with the ir-electrons of
the aromatic B-ring, which may tend to make the A-ring of S s ig n ifi
cantly more planar
anthracyclines.

thanthat

of the

therapeutically

interesting

Studies with an adriamycin derivative with a double

bond between the 9th and 10th carbons and therefore with a more
planar

A-ring

have

shown i t

to

have s ig n ific a n tly weakened DNA

binding and minimal antineoplastic a c tiv ity (Arcamone, 1980).
Bioalkvlation
Whether adriamycin or
electrons,

studies

daunomycin are reduced by one or two

haveshown

that

they

apparently

rearrange

e le c tro n ic a lly , q u a n titatively eliminate the sugar moiety, and form
th e ir respective 7-deoxyanthracyclinones.
the

7-deoxyanthracyclinones

methides.

are

tautomers

As Figures 4 and 11 show
of

th e ir

hydroquinone

According to Moore (1977) this species is a target for

nucleophilic attack by an in tra c e llu la r component.

Such an attack
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can result in bioalkylation of that bio-nucleophile.
If

quantitative elim ination of the sugar moiety is requisite

fo r anthracyclines to be bioalkylating agents and i f only a fraction
of the reduced S breaks down to 7-deoxysteffimycinone and steffose,
then S must be a poor bioalkylating agent.
Why

should

reduced

S

behave

d iffe re n tly

daunomycin, adriamycin, and sim ilar anthracyclines?

from

reduced

Perhaps when S

is reduced, intermediates form which are reasonably stable and non
productive from the standpoint of 7-deoxysteffimycinone formation.
Some of the possible reduction intermediates are shown in Figure
44.

The 10-carbonyl functional group of S appears to be able to

sta b iliz e a p a rtia l negative charge on the 10th carbon.

This type

of intermediate with a p a rtia l negative charge on the

carbon is

1 0 th

not stabilized in the adriamycin molecule.

HO
'OH
HO HO

HO

0 I

HO HO

HO

Figure 44.

Reduced S;

HO

HO

OH

Postulated hydroquinone tautomers.
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An altern ative explanation might be the follow ing.
S

semiquinone

were

capable

of

reductive

I f only the

elim ination,

if

the

elim ination reaction were slow, and i f the equilibrium constant fo r
the coproportionation reaction

in aqueous solutions were high as

illu s tra te d , then one might expect l i t t l e reductive cleavage.

2SH'

^ S + SHg
HjO

[SHg] »

[SH'J

7-deoxysteffimycinone t steffose
Autoxidation
Pietronigro et a l.

(1979) showed that the oxygen consumption

rate in solutions of enzymically reduced adriamycin decreased when
superoxide dismutase was added to the solution.
was unaffected
oxygen

consumption

decreased

when

concentration
sim ilar
produced

by catalase.
rate

catalase

of

solutions

was

However, the rate

investigator

added.

of

showed that

enzymically
This

implied

the

reduced
that

S

the

superoxide produced when reduced adriamycin and

anthracyclines
when

in

This

reduced

autoxidized
S was

was

much

autoxidized.

greater

than

that

Therefore

it

seems

probable that few damaging free-rad icals were produced during the
redox cycling of S.
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Enzyme
I t seems un likely that the enzyme found in S. steffisburqensis
cells and isolated fo r the studies reported in th is dissertation had
evolved

as a S reductase.

assertion.

There

are

several

reasons fo r

this

F ir s t, oxido-reductases ubiquitous to various microbial

species seem responsible fo r this a c tiv ity or a sim ilar a c tiv ity .
In addition to being found in both anthracycline-producing and some
non-producing species of Streptomyces. a sim ilar a c tiv ity has been
found in diverse organisms such as C. freundi. A. hvdrophila. and C.
simplex.

Secondly,

the enzyme was present,

as fa r

as could be

determined, in a ll stages of the S. steffisburqensis c e ll cycle in
fermentation medium designed to promote only c e ll growth.
no a n tib io tic

production.

Assuming that

enzyme production within microbial c e lls ,

there

is

There was

parsimony of

then this NADH-specific

oxido-reductase isolated from S. steffisburqensis probably does not
have

S as

substrate

its
and

Nevertheless,

natural
metabolic

substrate.
raison

Unfortunately,
d' être

remain

its

natural

undetermined.

some of the information gained about its properties

during the enzyme isolation and characterization studies and its in
v itro a c tiv ity was in teresting.

A review of this information and a

comparison of the enzyme isolated from S. steffisburqensis with some
of the mammalian anthracycline reducing enzymes described in the
lite ra tu re follow s.
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Enzyme Isolation and P u rification
The only significant d iff ic u ltie s encountered during the enzyme
isolation were maintaining the s t a b ility of the a c tiv ity in crude
extracts and balancing the a c tiv ity going into each isolation step
with that present a fte r each step.
the

enzyme

a c tiv ity

in

the

This had to do with determining

crude

samples.

d iffic u ltie s encountered were due to:

In

this

case

the

the tu rb id ity of the crude

enzyme samples, the deceleration of the in it i a l rate with time (as
mentioned before), and the possible removal of both S and NADH from
the assay solutions by virtue of th e ir binding to the impurities in
the

samples.

considerably

The enzyme s ta b ility
when

the

protease

in

crude

inhibitors

extracts

were

added

improved
to

the

extraction buffer.
Several things seemed remarkable.

One—there was very l i t t l e

enzyme by weight present in one-hundred grams of dry c e lls .

Two—

there was very appreciable p u rificatio n by the a f fin ity chromato
graphy step when the starting material for this step was a p a r tia lly
p urified enzyme preparation, and the enzyme-rich eluent from this
chromatography was nearly homogeneous.

Both standard and SDS gel

electrophoresis verified th is .
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Isolated Microbial Reductase Vs. Anthracycline Reductases
Characteristics
The

enzyme

recovered

in

isolated

the

from

supernatant

u ltrac en trifu g atio n .

steffisburqensis ce lls
when

a

cfe

it.

around pH 5,

groups

to

This soluble enzyme was

and p recipitation

Some detergents also inactivated

prosthetic

was

subjected

Therefore, the enzyme was neither particulate

nor associated with endoplasmic membranes.
insoluble

was

nor

it.

subunits.

at that pH inactivated
I t apparently had neither

The

highly

purified .enzyme

concentrates had a sharp pH optimum (an indication of homogeneity)
and i t only used NADH as its cofactor.
daunomycin

were

not

substrates

fo r

Surprisingly, adriamycin and
the

enzyme.

Warfarin,

an

in h ib ito r of enzymes lik e coenzyme Q reductase, inhibited the enzyme
as

did

agent.

p-(hydroxymercuri)benzoic

acid,

a

sulfhydryl

blocking

A serine protease in h ib ito r was ineffectual as were a metal

complexing agent and fla v in inactivators.

Adding rib o flavin to the

enzyme assay solutions neither increased nor decreased the reduction
ra te ,

which

seemed to

preclude

a

p o s s ib ility

that i t

was

an

apoenzyme of a riboflavin-containing enzyme.
Comparison
Many of the characteristics of mammalian enzymes are in sharp
contrast

to

th is .

Most

of

the

mammalian enzymes reported

to

reductively cleave anthracyclines were partic u late and used NADPH as
the cofactor (xanthine oxidase was the exception).

In addition, a ll
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contained

prosthetic groups. In most cases adriamycin was the best

substrate

fo r the reductive cleavage reaction, and th e ir pH optima

were generally around

8

.

Some of the known properties of xanthine

oxidase,

NADPH

cytochrome

microbial

reductase are in Table 16 for easy comparison.

P-450

reductase,

and

the

isolated

Some P r o p e r t ie s o f Mammalian R eductases and
th e I s o la t e d M ic r o b ia l R ed u ctase

P r o p e r ty

NADPH Cytochrom e P -4 5 0
Red u ctase

X a n th in e
O xid ase

S . s t e f f is b u r q e n s is
R ed u c ta s e

M W.

78K

300K

80K

P r o s t h e t ic
Groups

FAD and
FMN

Mo 6 +
FAD

None

P a r tic u la te

M icroso m al

No

L o c a te d

L iv e r , e tc .

Cream

No. o f e " t r a n s f e r r e d
a t a tim e

1 or 2

1

2 (? )

No
S . s t e f f is b u r q e n s is
c y to s o l

C o fa c to r(s )

NADPH

NADH

NADH

N a tu ra l S u b s tra te (s )

C ytochrom e P -4 5 0

x a n th in e

?

S iib u n lts

None
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Enzyme Mechanism
Knowing the complete mechanism of
include

knowing:

the

nature

of

both

a reductase must id e a lly
the

enzyme-substrate

and

enzyme-cofactor binding site s; the point at which the enzyme may be
i n i t i a l l y reduced and the type of reduction occurring; the point of
any secondary reductions within the enzyme and the type of reduction
occurring; the type of i n it i a l reduction occurring to the substrate;
the time sequence during the reduction course when the substrates
and cofactors

associate

and dissociate from the enzyme;

and the

velocity constant for the rate lim itin g step.

Since the reductase

isolated apparently had no prosthetic groups,

it

almost, but not

completely, eliminated the p o s s ib ility that reductions occurred on
or within the enzyme.

And although the nature of substrate and

cofactor binding sites may be probed chemically and to an extent
spectrophotometrically,

these cannot be determined with certainty

unless x-ray crystallography were done.

So the f i r s t three of the

mechanistic parameters lis te d above were judged inapplicable to this
enzyme, premature, or beyond the scope of this study.

Remaining to

be determined were the types of the reduction S was undergoing, the
binding sequence necessary to produce an NADH and S complex with the
enzyme that

resulted

in

electron

transfer

between cofactor

and

substrate ( i f sequence was indeed important in this case), the rate
lim iting step, and the velocity constant for this step.
As well as the parts of the enzyme mechanism ju st described.
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several additional observations needed to be explained to account
f u lly

fo r

reduced.

the Jn. v itro

processes occurring as S was enzymically

A few of these were:

dependence

of

the

i n it i a l

the decreasing i n it i a l rates, the

rate

on the

oxygen concentration

in

solution, and the interesting anthracycline s p e c ific itie s .
A Postulated Anaerobic Pathway
Shown in Figure 45 is a postulated course fo r the anaerobic,
enzymic S reduction at the expense of NADH.
complex with the enzyme.

I n i t i a l l y NADH and S

Neither the order of the binding nor even

the necessity for a partic u lar order is known, but for an enzyme
without a prosthetic group, the substrate and cofactor must not only
bind simultaneously to the enzyme but also bind so that they are
contiguous or nearly contiguous.

This condition must be met for

electron transfer from cofactor to substrate to occur.
Product

in h ib itio n

decreasing i n it i a l ra te .

was

postulated

as

the

cause

for

the

Product in hibitio n occurs when the enzyme-

product complex breaks down slowly.
removed from the reaction.

Thus the enzyme is e ffe c tiv e ly

I f product inhibitio n can be v e rifie d ,

then the rate lim itin g step fo r this reduction w ill be the enzymeproduct dissociation reaction.

A general kinetic feature of other

known NADH-dependent reductases is that they bind NADH more t ig h tly
than NAD'*’ (Fersht, 1977).

Therefore, i t seemed reasonable that NAD'*’

might dissociate from the enzyme before reduced S dissociates.

Most

reduced S dissociated from the enzyme since i t was detectable in the
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anaerobic assay solutions.
The molecular structure of the reduced S species remains to be
v e rifie d .

Its properties as determined using polarography, hplc,

and the oxygen electrode, however,

seemed consistent with those of

the S hydroquinone.

I f the S hydroquinone is the reduction product

formed

two

then

eith er

electrons

or

a hydride

ion

are

being

transferred from NADH to S at the enzyme's active s ite .
Once the S hydroquinone is in aqueous solution containing S i t
must

coproportionate

to

form

the

semiquinone.

Although

the

concentration of semiquinone in solution in th is case is apparently
low as demonstrated by ESR,
elimination

in

if

the electronic

rearrangement and

the S semiquinone were complete and rapid,

as a

resu lt of the very low aqueous s o lu b ility of 7-deoxysteffimycinone,
a ll

of the S reduced would s t i l l

be converted to the 7-deoxya-

glycone.
Aerobic Mechanism
The mechanism becomes s lig h tly more complicated when the in
v itro enzymic reduction occurs in a ir saturated solutions.

Under

these conditions the product was believed to be rapidly autoxidized
as

it

formed;

exactly

how rapidly

occurred was undetermined.

th is

autoxidation

actually

So most of the reaction sequence is

probably sim ilar to that outlined for the anaerobic reduction in
Figure 45.
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S+NADH

E'SH.
SH
S = steffim ycin, NAD = nicotine adenine dinucleotide
NADH = reduced NAD , SHp= reduced S,
E = S. steffisburqensis reductase

Figure 45.

Postulated anaerobic enzyme mechanism.
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The only differences resu lt from the reduced S reacting with
oxygen.

The evidence fo r this was that no spectral changes in S

corresponding to either a concentration or intramolecular electronic
change

were

observable

during

the

enzymic

reduction,

that

the

concentration of oxygen in the assay solution seemed to decrease
immediately when eith er
reaction,

and

that

added NADH or

the

decrease

in

added enzyme started
NADH concentration

the

roughly

corresponded to the decrease in oxygen concentration.
Effect of Oxygen Concentration
The

i n it i a l

rate

of

the

reduction

seemed to

related to the oxygen concentration in the solution.
explanations that this
were:

be

inversely

The only two

investigator considered plausible fo r this

one, that the S autoxidized in the active s ite as i t

was

being reduced, possibly generating a reactive species such as the
semiquinone capable of covalently binding to the enzyme s ite ; and
two, that oxygen might associate with S or the enzyme, therefore
diminishing the a ffin ity of S and the enzyme for each other.
Further Experiments
Many unanswered questions remain.

Much needs to be learned

through experimentation about not only the molecular structure and
configuration of S and its derivatives but also its redox chemistry
in aqueous solutions.

More needs to be determined about the nature

of the enzyme and its metabolic context within the microbial c e ll.
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Several studies that might improve the understanding of S and of the
enzyme follow .
Isolating
determining
important

the

th e ir

next

enzymically
molecular

experimental

would be desirable also:

and

inorganically

structures
step,

but

is

reduced

probably

determining

S and

the

most

the following

the coproportionation-disproportionation

equilibrium constant of S in aqueous solution and the configuration
around its A -ring.
A

good

place

to

begin

looking

for

the

enzyme's

natural

substrate might be among the derivatives of both vitamin K and
coenzyme Q.

Another approach to determining the "true" jn

vivo

function of the enzyme would involve determining i f any commercially
available

reductases

without

prosthetic

groups

have

sim ilar

s p e c ific itie s and reduce S in the same way.
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L ite ra tu re Summary I : Published anthracycline reduction ra te s by
p u rifie d mammalian enzymes compared

Researcher

Oxido-reductase

Pan (81)

NADPH-cytochrome P-450
Xanthine oxidase
Xanthine oxidase
N itra te reductase
N itra te reductase
NADH-cytochrome c

Pan (80)

Xanthine oxidase

Komlyama (79)
J. o f A n tib lo t.

Xanthine oxidase

Mitochondrial NAOHdehydroqenase ■
DT-d1aphorase
Bachur (79)

NADPH-cytochrome P-450

Okl (77)

NADPH cytochrome c

Rate 1 ,
nmol m1n-l
mg

Rate 2
nmol-mln-l
mg

7.120
110
250
94
7
97

19,500
-190
-220

114
102
152
225
10
0
4.4
.18.5*
18.9
30.4
1.2

^(mM)

Cosubstrate
(mM)

2,000
132

d
d
d
d
d
d

(0 .5 )
(0 .5 )
(0 .5 )
(0 .5 )
(0 .5 )
(0 .5 )

NADPH (1 .0 )
Xanthine (1 .0 )
NADH (1 .0 )
NADPH (1 .0 )
NADH (1 .0 )
NADH (1 .0 )

-190
-13
-262
214
8
0

d
d
d
d
d
d

(0 .5 )
(0 .5 )
(0 .5 )
(0 .5 )
(0 .5 )
(0 .5 )

Xanthine (1 .0 )
Glycoaldehyde
Purine (1 .0 )
NADH (1 .0 )
NADPH (1 .0 )
P terln e (1 .0 )

..

0.4
Rate 3
r; i2 0
890
32
53*
39
45*
111
154*
407
633
892
359

Anthra-

„

"

ac (0 .2 )
ac (0 .2 )
a (0 .2 )
d (0 .2 )
a (0 .2 )

Xanthine (0 .2 )
Xanthine (0 .2 )
Xanthine (0 .2 )
Xanthine (0 .2 )
NADH (0 .2 )

a (0 .2 )

NADH (0 .2 )

a (0 .1 )
d (0 .1 )

NADPH (5 .0 )
NADPH ( 5 .0

ac (0 .1 )
ac (0 .1 )
dp (0 .1 )
dp (0 .1 )
ak (0 .1 )
ak (0 .1 )
a (0 .1 )
ao (0 .1 )
d (0 .1 )
do (0 .1 )

NADPH
NADPH
NADPH
NADPH
NADPH
NADPH
NADPH
NADPH
NADPH
NADPH

(0 .2 )
(0 .2 )
(0 .2 )
(0 .2 )
(0 .2 )
(0 .2 )
(0 .2 )
(0 .2 )
(0 .2 )
(0 .2 )

Rate 1 = A [7 -deo xyag lyco n e]-A t-l: Rate 2 = ACOg] A t-1 ; and Rate 3 = A[NADPH]-At-1;
* ■ A[7-deoxyaglycone d im e r]*A t*l; d = daunomycin; a = adrlamycin; ac = aclaclnomycin;
dp » 1-deoxypyrromycln; ak » aklavlnone; ao = adriamyclnone; do = daunomycinone
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Appendix B

L ite ra tu re Summary I I :
Published anthracycline reduction ra te s by
mammalian tissu e extrac ts compared

Researcher

Tissue ex trac ts

Ruekert (79)

R at-1iv er homogenate

Rate 1
nm ol-m in-l-m g-l

17.6
1.4
2.5

Cycline
(mM)

Cosubstrate
(mM)

a (0 .4 )
n (0 .4 )
7-OMENal
(0 .4 )

NADPH (1 .5 )
NADPH ( 1 .5 )
NADPH (1 .5 )

1.0

Komiyama (79)
Gann

Bachur (78)

(0 .4 )
S (0 .4 )
SB (0 .4 )

NADPH ( 1 .5 )
NADPH (1 .5 )

mitochondria
lysosomes
microsomes
soluble

0.4
0.4
0 .8
0 .2
0.4

ac
ac
ac
ac
ac

NADH
NADH
NADH
NADH
NADH

mitochondria
lysosomes
microsomes
soluble

3 .8
1.2
5 .0
11.2
0.6

a
a
a
a
a

R at-1iv er fra c tio n :

R at-1iv er microsomes
R at-1iv er microsomes

Key:

NADPH ( 1 .5 )

0.4
0 .5

Rate 2
81
73

.

(0 .5 )
(0 .5 )
(0 .5 )
(0 .5 )
(0 .5 )
(0 .5 )
(0 .5 )
(0 .5 )
(0 .5 )
(0 .5 )

(0 .2 )
(0 .2 )
(0 .2 )
(0 .2 )
(0 .2 )

NADPH
NADPH
NADPH
NADPH
NADPH

(0 .2 )
(0 .2 )
(0 .2 )
( 0 .2 )
(0 .2 )

a (0 .5 )

NADPH (6 .0 )

a (0 .1 )

NADPH (0 .2 )

Rate 1 = A [7-deoxyaglycone] A f l ; Rate 2 = û [ 0 2 ] - A t - l; Rate 3 = &[NADPH] & t - l ,
a ■ adriamycin; ac = aclaclnomycin; n = nogalamycin; 7-OMENal = 7-0-m ethylnogalarol;
7-OMEN = 7-0-m ethylnogarol; S = s te ffim y c in ; SB = ste ffim y cin B.
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L ite ra tu re Summary I I I :
Published anthracycline reduction ra te s by
m icrobial ex trac ts compared

Researcher

Microbe

Ruekert (79 )

S. nooalater
c e ll f re e e x trac t
(c fe )

Rate 1
nmol•min-l-mg-l
0.06
0.09
0.07
0.04
0.02
—

M arshall (78)

S. s te ffis b e rq en s is

M cC arville (77)

S. s te ffis b e rq en s is
p u rifie d enzyme

W iley (77)

S. n o q a lito r
c fe ----------

Key:

0 .2

73

0 .4

Cycline
(mM)

Cosubstrate
(mM)

a (0 .4 )
n (0 .4 )
7-OMENal
( 0 .4 )
7-OMEN
(0 .4 )
S (0 .4 )
SB (0 .4 )

NADH ( 1 .5 )
NADH ( 1 .5 )
NADH ( 1 .5 )

NADH (1 .5 )
NADH (1 .5 )

a (1 .5 )

NADH (1 .5 )

S (1 .2 5 )

lOd sone
(0 .9 )

NADH (1 .5 )

NADH (5 .4 )

NADH (1 .3 )

Rate = û[7-d eo xy aq ly co n e ]-A t-l; a = adrlamycin; n = noqalamycin;
7-OMENal = 7 -0 -m e th y ln o g ala ro l; 7-OMEN = 7-0-methylnogarol; S = s te ffim y cin ;
SB « ste ffim y cin B; lOd sone = 10-dihydrosteffim ycinone
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UV-Visible Spectra of Steffimycin
in O.IN Aqueous Buffers
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